Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 10
2021 112
2022 194
2023 111
2024 54
2025 36
2026 19

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

485 results

Results by year

Filters applied: . Clear all
Page 1
COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals.
Faksova K, Walsh D, Jiang Y, Griffin J, Phillips A, Gentile A, Kwong JC, Macartney K, Naus M, Grange Z, Escolano S, Sepulveda G, Shetty A, Pillsbury A, Sullivan C, Naveed Z, Janjua NZ, Giglio N, Perälä J, Nasreen S, Gidding H, Hovi P, Vo T, Cui F, Deng L, Cullen L, Artama M, Lu H, Clothier HJ, Batty K, Paynter J, Petousis-Harris H, Buttery J, Black S, Hviid A. Faksova K, et al. Vaccine. 2024 Apr 2;42(9):2200-2211. doi: 10.1016/j.vaccine.2024.01.100. Epub 2024 Feb 12. Vaccine. 2024. PMID: 38350768 Free article.
BACKGROUND: The Global COVID Vaccine Safety (GCoVS) Project, established in 2021 under the multinational Global Vaccine Data Network (GVDN ), facilitates comprehensive assessment of vaccine safety. ...Expected rates were obtained by participating site …
BACKGROUND: The Global COVID Vaccine Safety (GCoVS) Project, established in 2021 under the multinational Global Vaccine …
New-onset autoimmune phenomena post-COVID-19 vaccination.
Chen Y, Xu Z, Wang P, Li XM, Shuai ZW, Ye DQ, Pan HF. Chen Y, et al. Immunology. 2022 Apr;165(4):386-401. doi: 10.1111/imm.13443. Epub 2022 Jan 7. Immunology. 2022. PMID: 34957554 Free article. Review.
Coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to an unprecedented setback for global economy and health. ...In fact, we do not aim to disavow the overwhelming b …
Coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS- …
Guillain-Barre syndrome: An autoimmune disorder post-COVID-19 vaccination?
Khan Z, Ahmad U, Ualiyeva D, Amissah OB, Khan A, Noor Z, Zaman N. Khan Z, et al. Clin Immunol Commun. 2022 Dec;2:1-5. doi: 10.1016/j.clicom.2021.12.002. Epub 2021 Dec 23. Clin Immunol Commun. 2022. PMID: 38620684 Free PMC article. Review.
SARS-CoV-2 causes Coronavirus Disease 2019 (COVID-19), an infectious condition that can present none or one or more of these symptoms: fever, cough, headache, sore throat, loss of taste and smell, aches, fatigue and musculoskeletal pain. ...Here …
SARS-CoV-2 causes Coronavirus Disease 2019 (COVID-19), an infectious condition that can present none or o …
Guillain-Barre Syndrome Following the BNT162b2 mRNA COVID-19 Vaccine.
Algahtani HA, Shirah BH, Albeladi YK, Albeladi RK. Algahtani HA, et al. Acta Neurol Taiwan. 2023 Jun 30;32(2):82-85. Acta Neurol Taiwan. 2023. PMID: 37198513 Free article.
One of these severe adverse events is Guillain-Barre syndrome. CASE REPORT: Here, we describe a case of Guillain-Barre syndrome after the first dose of the BNT162b2 mRNA COVID-19 vaccine and review the literature to increase the cu …
One of these severe adverse events is Guillain-Barre syndrome. CASE REPORT: Here, we describe a case of Guillain-Bar …
Guillain-Barre syndrome following COVID-19 vaccines: A review of literature.
Yu M, Nie S, Qiao Y, Ma Y. Yu M, et al. Front Immunol. 2023 Feb 15;14:1078197. doi: 10.3389/fimmu.2023.1078197. eCollection 2023. Front Immunol. 2023. PMID: 36875094 Free PMC article. Review.
OBJECTIVE: This study aimed to retrospectively analyze reported Guillain-Barre syndrome (GBS) cases that occurred after COVID-19 vaccination. METHODS: Case reports of GBS following COVID-19 vaccination that were published be …
OBJECTIVE: This study aimed to retrospectively analyze reported Guillain-Barre syndrome (GBS) cases that occurred after COV …
Guillain- Barre Syndrome Associated with COVID-19 Vaccination.
Shao SC, Wang CH, Chang KC, Hung MJ, Chen HY, Liao SC. Shao SC, et al. Emerg Infect Dis. 2021 Dec;27(12):3175-3178. doi: 10.3201/eid2712.211634. Epub 2021 Oct 14. Emerg Infect Dis. 2021. PMID: 34648420 Free PMC article.
We conducted a multi-institutional study in Taiwan and a systematic review of the literature for reports of Guillain- Barre syndrome after coronavirus disease vaccination. This condition, mostly the classic form and the acute inflammatory demyelinating polyne …
We conducted a multi-institutional study in Taiwan and a systematic review of the literature for reports of Guillain- Barre sy …
Guillain-Barre syndrome and COVID-19 vaccination: a systematic review and meta-analysis.
Censi S, Bisaccia G, Gallina S, Tomassini V, Uncini A. Censi S, et al. J Neurol. 2024 Mar;271(3):1063-1071. doi: 10.1007/s00415-024-12186-7. Epub 2024 Jan 17. J Neurol. 2024. PMID: 38233678 Free PMC article.
BACKGROUND: Case-reports/series and cohorts of Guillain-Barre syndrome (GBS) associated with COVID-19 vaccination have been reported. METHODS: A systematic review and meta-analysis of cohort studies of GBS after COVID-19 vaccina …
BACKGROUND: Case-reports/series and cohorts of Guillain-Barre syndrome (GBS) associated with COVID-19 vaccina …
AstraZeneca COVID-19 vaccine and Guillain- Barre Syndrome in Tasmania: A causal link?
Oo WM, Giri P, de Souza A. Oo WM, et al. J Neuroimmunol. 2021 Nov 15;360:577719. doi: 10.1016/j.jneuroim.2021.577719. Epub 2021 Sep 17. J Neuroimmunol. 2021. PMID: 34560365 Free PMC article. Review.
The emergence of the coronavirus 2019 (COVID-19) pandemic has presented an unprecedented global challenge. Vaccines against COVID have been developed to date. Covid-19 has been linked with the development of Guillain-Barre S …
The emergence of the coronavirus 2019 (COVID-19) pandemic has presented an unprecedented global challenge. Vaccines aga …
Guillain-Barre syndrome in association with COVID-19 vaccination: a systematic review.
Abolmaali M, Rezania F, Behnagh AK, Hamidabad NM, Gorji A, Mirzaasgari Z. Abolmaali M, et al. Immunol Res. 2022 Dec;70(6):752-764. doi: 10.1007/s12026-022-09316-6. Epub 2022 Sep 13. Immunol Res. 2022. PMID: 36098903 Free PMC article.
Since the beginning of worldwide vaccination against coronavirus disease 2019 (COVID-19), studies have reported a possible association between vaccination and Guillain-Barre syndrome (GBS). ...Overall, a small rise in GBS incidence, follo …
Since the beginning of worldwide vaccination against coronavirus disease 2019 (COVID-19), studies have reported a possi …
Guillain-Barre Syndrome and COVID-19 Vaccine: A Report of Nine Patients.
Karimi N, Boostani R, Fatehi F, Panahi A, Asghar Okhovat A, Ziaadini B, Basiri K, Abdi S, Sinaei F, Rezaei M, Shamsaei G, Ansari B, Nafissi S. Karimi N, et al. Basic Clin Neurosci. 2021 Sep-Oct;12(5):703-710. doi: 10.32598/bcn.2021.3565.1. Epub 2021 Sep 1. Basic Clin Neurosci. 2021. PMID: 35173924 Free PMC article.
Several studies reported GBS associated with Coronavirus Disease 2019 (COVID-19) infection. In this study, we described nine GBS patients following the COVID-19 vaccine. ...All patients were discharged with some improvements. CONCLUSION: The lin …
Several studies reported GBS associated with Coronavirus Disease 2019 (COVID-19) infection. In this study, we described nine G …
Association of Guillain-Barre syndrome following COVID-19 vaccination.
Chowdhury S, Chowdhury S. Chowdhury S, et al. Int J Immunopathol Pharmacol. 2023 Jan-Dec;37:3946320231199349. doi: 10.1177/03946320231199349. Int J Immunopathol Pharmacol. 2023. PMID: 37681361 Free PMC article. Review.
Background: Among the various side-effects of COVID-19 vaccinations, Guillain-Barre syndrome (GBS) has been found to have some interesting association with the vaccinations. This paper mainly focuses on exploring different associations be …
Background: Among the various side-effects of COVID-19 vaccinations, Guillain-Barre syndrome (GBS) has be …
Effects of COVID-19 vaccine type on Guillain-Barre syndrome: Two cases and a literature review.
Lee HY, Lien WC. Lee HY, et al. Hum Vaccin Immunother. 2023 Dec 31;19(1):2171231. doi: 10.1080/21645515.2023.2171231. Epub 2023 Feb 22. Hum Vaccin Immunother. 2023. PMID: 36919452 Free PMC article. Review.
Guillain-Barre syndrome (GBS) is a rare but severe complication of COVID-19 vaccination. ...However, incidence cannot be accurately estimated from case reports. Thus, the true GBS rates following COVID-19 vaccination should …
Guillain-Barre syndrome (GBS) is a rare but severe complication of COVID-19 vaccination. ...However, inci …
Prognosis of Guillain-Barre Syndrome Linked to COVID-19 Vaccination.
Chua SKK, Soh QY, Saffari SE, Tan EK. Chua SKK, et al. Brain Sci. 2022 May 30;12(6):711. doi: 10.3390/brainsci12060711. Brain Sci. 2022. PMID: 35741597 Free PMC article.
There have been increasing reports of Guillain-Barre syndrome (GBS), a rare but debilitating neurological disease, occurring post-COVID-19 vaccination. However, the outcomes and relationships between patient demographics and clinical outcomes of …
There have been increasing reports of Guillain-Barre syndrome (GBS), a rare but debilitating neurological disease, occurring p …
Guillain-Barre syndrome following BNT162b2 COVID-19 vaccine.
Trimboli M, Zoleo P, Arabia G, Gambardella A. Trimboli M, et al. Neurol Sci. 2021 Nov;42(11):4401-4402. doi: 10.1007/s10072-021-05523-5. Epub 2021 Aug 4. Neurol Sci. 2021. PMID: 34346014 Free PMC article. No abstract available.
Post COVID-19 vaccine Guillain-Barre syndrome.
Khadka B, Khanal K. Khadka B, et al. J Nepal Health Res Counc. 2022 Mar 13;19(4):852-854. doi: 10.33314/jnhrc.v19i04.3803. J Nepal Health Res Counc. 2022. PMID: 35615850
Guillain-Barre syndrome is an acute generalized polyneuropathy which usually follows infection with a virus or bacteria, although rarely vaccination may be associated with it. ...Only potential triggering factor in this case was positive finding of Jansen …
Guillain-Barre syndrome is an acute generalized polyneuropathy which usually follows infection with a virus or bacteria, altho …
The Impact of COVID-19 on the Guillain-Barre Syndrome Incidence.
Kopańko M, Zabłudowska M, Zajkowska M, Gudowska-Sawczuk M, Mucha M, Mroczko B. Kopańko M, et al. Biomedicines. 2024 Jun 4;12(6):1248. doi: 10.3390/biomedicines12061248. Biomedicines. 2024. PMID: 38927455 Free PMC article. Review.
Despite the fact that the global COVID-19 pandemic has officially ended, we continue to feel its effects and discover new correlations between SARS-CoV-2 infection and changes in the organism that have occurred in patients. ...This article is a …
Despite the fact that the global COVID-19 pandemic has officially ended, we continue to feel its effects and discover new corr …
COVID-19 vaccine type and Guillain-Barre syndrome: Comment.
Kleebayoon A, Wiwanitkit V. Kleebayoon A, et al. Hum Vaccin Immunother. 2023 Dec 31;19(1):2200355. doi: 10.1080/21645515.2023.2200355. Epub 2023 Apr 24. Hum Vaccin Immunother. 2023. PMID: 37096296 Free PMC article. No abstract available.
Guillain-Barre syndrome after COVID-19 vaccination.
McKean N, Chircop C. McKean N, et al. BMJ Case Rep. 2021 Jul 30;14(7):e244125. doi: 10.1136/bcr-2021-244125. BMJ Case Rep. 2021. PMID: 34330729 Free PMC article.
We report a case of Guillain-Barre syndrome (GBS) occurring soon after the first dose of Vaxzevria (previously known as COVID-19 vaccine AstraZeneca). Thus far, there has been no evidence of an increased risk of GBS resulting from either COVI …
We report a case of Guillain-Barre syndrome (GBS) occurring soon after the first dose of Vaxzevria (previously known as COV …
Incidence of Guillain-Barre Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink.
Hanson KE, Goddard K, Lewis N, Fireman B, Myers TR, Bakshi N, Weintraub E, Donahue JG, Nelson JC, Xu S, Glanz JM, Williams JTB, Alpern JD, Klein NP. Hanson KE, et al. JAMA Netw Open. 2022 Apr 1;5(4):e228879. doi: 10.1001/jamanetworkopen.2022.8879. JAMA Netw Open. 2022. PMID: 35471572 Free PMC article.
OBJECTIVE: To describe cases and incidence of GBS following COVID-19 vaccination and assess the risk of GBS after vaccination for Ad.26.COV2.S (Janssen) and mRNA vaccines. ...In a head-to-head comparison of Ad.26.COV2.S vs mRNA vaccines, …
OBJECTIVE: To describe cases and incidence of GBS following COVID-19 vaccination and assess the risk of GBS after va …
COVID-19 as a trigger of Guillain-Barre syndrome: A review of the molecular mechanism.
Malekpour M, Khanmohammadi S, Meybodi MJE, Shekouh D, Rahmanian MR, Kardeh S, Azarpira N. Malekpour M, et al. Immun Inflamm Dis. 2023 May;11(5):e875. doi: 10.1002/iid3.875. Immun Inflamm Dis. 2023. PMID: 37249286 Free PMC article. Review.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a pandemic with serious complications. After coronavirus disease 2019 (COVID-19), several post-acute COVID-19 syndromes (PACSs) and long-COVID sequel …
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a pandemic with serious complications. After …
Guillain-Barre Syndrome and COVID-19 Vaccine: A Multicenter Retrospective Study of 46 Cases.
Castiglione JI, Crespo JM, Bendersky M, Silveira FO, Lecchini L, Luis MB, Zambrano FC, Cotti N, Simison CJ, Aguirre F, Piedrabuena MA, Alonso RN, Azcona CL, Sosa PS, Maldonado E, Varela F, Bettini M, Rey RD, Cejas LL, Rugiero M, Reisin R, Barroso F. Castiglione JI, et al. J Clin Neuromuscul Dis. 2023 Sep 1;25(1):1-10. doi: 10.1097/CND.0000000000000437. J Clin Neuromuscul Dis. 2023. PMID: 37611264
In the context of the global vaccination campaign against COVID-19, several cases of postvaccinal Guillain-Barre syndrome (GBS) were reported. ...We investigated the clinical and electromyographic characteristics of patients who developed GBS af …
In the context of the global vaccination campaign against COVID-19, several cases of postvaccinal Guillain-Ba …
Neuro-COVID-19.
Shimohata T. Shimohata T. Clin Exp Neuroimmunol. 2022 Feb;13(1):17-23. doi: 10.1111/cen3.12676. Epub 2021 Sep 29. Clin Exp Neuroimmunol. 2022. PMID: 34899999 Free PMC article. Review.
The sequelae, called post-acute COVID-19 syndrome or long COVID, include neuromuscular manifestations, such as anxiety, depression, sleep disturbance, muscle weakness, brain fog and cognitive impairment. It is desirable to establish diagnostic criteria and tr …
The sequelae, called post-acute COVID-19 syndrome or long COVID, include neuromuscular manifestations, such as anxiety, …
Guillain-Barre syndrome after vaccination against COVID-19.
Chun JY, Park S, Jung J, Kim SH, Kim TS, Choi YJ, Kim HJ, Eom HS, Hyun JW. Chun JY, et al. Lancet Neurol. 2022 Feb;21(2):117-119. doi: 10.1016/S1474-4422(21)00416-6. Epub 2021 Dec 17. Lancet Neurol. 2022. PMID: 34929194 Free PMC article. No abstract available.
Guillain-Barre Syndrome Induced by Vaccination Against COVID-19: A Systematic Review and Meta-Analysis.
Ogunjimi OB, Tsalamandris G, Paladini A, Varrassi G, Zis P. Ogunjimi OB, et al. Cureus. 2023 Apr 14;15(4):e37578. doi: 10.7759/cureus.37578. eCollection 2023 Apr. Cureus. 2023. PMID: 37193456 Free PMC article. Review.
Two-thirds of cases of GBS are diagnosed following infection; however, vaccination has also been linked to GBS pathogenesis. The aim of this systematic review and meta-analysis was to establish the prevalence of GBS following vaccination against the SARS-C …
Two-thirds of cases of GBS are diagnosed following infection; however, vaccination has also been linked to GBS pathogenesis. The aim …
Guillain-Barre syndrome and COVID-19 vaccines: focus on adenoviral vectors.
Rzymski P. Rzymski P. Front Immunol. 2023 Apr 26;14:1183258. doi: 10.3389/fimmu.2023.1183258. eCollection 2023. Front Immunol. 2023. PMID: 37180147 Free PMC article.
COVID-19 vaccination is a life-saving intervention. However, it does not come up without a risk of rare adverse events, which frequency varies between vaccines developed using different technological platforms. The increased risk of Guillain- …
COVID-19 vaccination is a life-saving intervention. However, it does not come up without a risk of rare adverse events, …
Guillain-Barre Syndrome Following the Administration of Adenovirus Vector-Based COVID-19 Vaccine.
Lee ML, Bautista JMP. Lee ML, et al. Cureus. 2023 Jul 23;15(7):e42316. doi: 10.7759/cureus.42316. eCollection 2023 Jul. Cureus. 2023. PMID: 37614248 Free PMC article.
As countries worldwide deployed their respective coronavirus disease 2019 (COVID-19) vaccination programs to mitigate the risk of COVID-19 to their citizens, several side effects and complications from the use of the various types of COVID …
As countries worldwide deployed their respective coronavirus disease 2019 (COVID-19) vaccination programs to mitigate t …
Systematic Review and Meta-Analysis of the Incidence of Myocarditis and Guillain-Barre Syndrome in Adolescents Receiving COVID-19 mRNA Vaccine.
Kumar C, Akhileshwar, Kumar Neeraj R, Hameed S, Husain N, Roy SS, Mohan L, Anantsaznam. Kumar C, et al. Cureus. 2025 Nov 30;17(11):e98208. doi: 10.7759/cureus.98208. eCollection 2025 Nov. Cureus. 2025. PMID: 41488264 Free PMC article. Review.
This study aimed to evaluate the incidence and risk of rare long-term adverse events, specifically myocarditis and Guillain-Barre syndrome (GBS), in adolescents (12-19 years) following COVID-19 mRNA vaccination. ...COVID-19 mRNA …
This study aimed to evaluate the incidence and risk of rare long-term adverse events, specifically myocarditis and Guillain-Barre …
Guillain-Barre syndrome following COVID-19 vaccines: A scoping review.
Lahoz Fernandez PE, Miranda Pereira J, Fonseca Risso I, Baleeiro Rodrigues Silva P, Freitas Barboza IC, Vieira Silveira CG, Diogo Silva G, Marzorati Kuntz Puglia P, Genaro Mutarelli E. Lahoz Fernandez PE, et al. Acta Neurol Scand. 2022 Apr;145(4):393-398. doi: 10.1111/ane.13575. Epub 2021 Dec 29. Acta Neurol Scand. 2022. PMID: 34967005
Guillain-Barre syndrome following COVID-19 vaccines (GBSfCV19v) is a reported adverse effect that remains unclear. ...We've searched on MEDLINE and Embase, from the inception to May 20, 2021, using the keywords: "Guillain barre syn …
Guillain-Barre syndrome following COVID-19 vaccines (GBSfCV19v) is a reported adverse effect that remains …
Updated Evidence for Covid-19, RSV, and Influenza Vaccines for 2025-2026.
Scott J, Abers MS, Marwah HK, McCann NC, Meyerowitz EA, Richterman A, Fleming DF, Holmes EJ, Moat LE, Redepenning SG, Smith EA, Stoddart CJ, Sundaram ME, Ulrich AK, Alba C, Anderson CJ, Arpey MK, Borre E, Ladines-Lim J, Mehr AJ, Rich K, Watts C, Basta NE, Jarolimova J, Walensky RP, Dugdale CM. Scott J, et al. N Engl J Med. 2025 Dec 4;393(22):2221-2242. doi: 10.1056/NEJMsa2514268. Epub 2025 Oct 29. N Engl J Med. 2025. PMID: 41160817
The diagnosis of myocarditis associated with Covid-19 vaccines occurred at rates of 1.3 to 3.1 per 100,000 doses in male adolescents, with lower risk associated with longer dosing intervals. The RSVpreF vaccine was associated with 18.2 excess cases of …
The diagnosis of myocarditis associated with Covid-19 vaccines occurred at rates of 1.3 to 3.1 per 100,000 doses in mal …
Guillain-Barre Syndrome After a SARS-CoV-2 Vaccine.
Oliveira AM, Varela Ramos P, Durão-Carvalho G, Almeida V, Gonçalves Pereira J. Oliveira AM, et al. Cureus. 2024 Apr 6;16(4):e57705. doi: 10.7759/cureus.57705. eCollection 2024 Apr. Cureus. 2024. PMID: 38711707 Free PMC article.
The worldwide mass vaccination campaign against COVID-19 has been the largest one ever undertaken. Although the short-term safety profile of the different vaccines has been well established, neuroinflammatory complications have been described, includin …
The worldwide mass vaccination campaign against COVID-19 has been the largest one ever undertaken. Although the short-t …
Post-COVID vaccination Guillain-Barre syndrome.
Finsterer J. Finsterer J. Br J Clin Pharmacol. 2023 Mar;89(3):1224-1225. doi: 10.1111/bcp.15649. Epub 2023 Jan 4. Br J Clin Pharmacol. 2023. PMID: 36600361 Free article. No abstract available.
Guillain-Barre syndrome and link with COVID-19 infection and vaccination: a review of literature.
Valaparla VL, Rane SP, Patel C, Li X. Valaparla VL, et al. Front Neurol. 2024 Jun 5;15:1396642. doi: 10.3389/fneur.2024.1396642. eCollection 2024. Front Neurol. 2024. PMID: 38899056 Free PMC article. Review.
We also reviewed studies that included vaccines against COVID-19 in association with GBS. Studies that focused on understanding the pathobiology of GBS and its association with infectious agents including COVID-19 were reviewed. CONCLUSION: Desp …
We also reviewed studies that included vaccines against COVID-19 in association with GBS. Studies that focused on under …
Guillain-Barre syndrome before and during the COVID-19 pandemic in a referral center of Mexico.
López-Hernández JC, Vargas-Cañas ES, Estrada SA, Galnares-Olalde J. López-Hernández JC, et al. Gac Med Mex. 2023;159(4):315-321. doi: 10.24875/GMM.M23000787. Gac Med Mex. 2023. PMID: 37699231 Free article. English.
BACKGROUND: During the COVID-19 pandemic, an increase in the number of Guillain-Barre syndrome (GBS) cases has been reported. ...There were no significant differences in independent ambulation recovery or in the number of deaths. CONCLUSIONS: During th …
BACKGROUND: During the COVID-19 pandemic, an increase in the number of Guillain-Barre syndrome (GBS) cases has b …
COVID-19 vaccination and Guillain-Barre syndrome: analyses using the National Immunoglobulin Database.
Keh RYS, Scanlon S, Datta-Nemdharry P, Donegan K, Cavanagh S, Foster M, Skelland D, Palmer J, Machado PM, Keddie S, Carr AS, Lunn MP; BPNS/ABN COVID-19 Vaccine GBS Study Group. Keh RYS, et al. Brain. 2023 Feb 13;146(2):739-748. doi: 10.1093/brain/awac067. Brain. 2023. PMID: 35180300 Free PMC article.
Vaccination against viruses has rarely been associated with Guillain-Barre syndrome (GBS), and an association with the COVID-19 vaccine is unknown. ...One hundred and ninety-eight GBS cases occurred within 6 weeks of the first-dose COV …
Vaccination against viruses has rarely been associated with Guillain-Barre syndrome (GBS), and an association with the …
COVID-19 vaccine-related Guillain-Barre syndrome in the Liguria region of Italy: A multicenter case series.
Germano F, Bellucci M, Grisanti S, Beronio A, Grazzini M, Coco E, Tassinari T, Della Cava F, De Michelis C, Baldi O, Sivori G, Murialdo A, Cabona C, Durando P, Uccelli A, Schenone A, Franciotta D, Benedetti L. Germano F, et al. J Neurol Sci. 2022 Sep 15;440:120330. doi: 10.1016/j.jns.2022.120330. Epub 2022 Jun 25. J Neurol Sci. 2022. PMID: 35802961 Free PMC article.
BACKGROUND AND PURPOSE: Guillain-Barre-Syndrome (GBS) can follow COVID-19 vaccination, with clinical and paraclinical features still to be precisely assessed. ...CONCLUSIONS: Our findings confirm that most post-COVID-19 vaccinat …
BACKGROUND AND PURPOSE: Guillain-Barre-Syndrome (GBS) can follow COVID-19 vaccination, with clinical and …
A Clinical Case of COVID-19 Vaccine-Associated Guillain-Barre Syndrome.
Hilts A, Schreiber A, Singh A. Hilts A, et al. Am J Case Rep. 2022 Aug 10;23:e936896. doi: 10.12659/AJCR.936896. Am J Case Rep. 2022. PMID: 35945825 Free PMC article.
While there were no reported cases of GBS during the mRNA COVID-19 vaccination clinical trials, there have been a few case reports of GBS following COVID-19 vaccination. ...The combination of the patient's CSF findings and clinical sympto …
While there were no reported cases of GBS during the mRNA COVID-19 vaccination clinical trials, there have been a few c …
Surveillance for Adverse Events After COVID-19 mRNA Vaccination.
Klein NP, Lewis N, Goddard K, Fireman B, Zerbo O, Hanson KE, Donahue JG, Kharbanda EO, Naleway A, Nelson JC, Xu S, Yih WK, Glanz JM, Williams JTB, Hambidge SJ, Lewin BJ, Shimabukuro TT, DeStefano F, Weintraub ES. Klein NP, et al. JAMA. 2021 Oct 12;326(14):1390-1399. doi: 10.1001/jama.2021.15072. JAMA. 2021. PMID: 34477808 Free PMC article.
IMPORTANCE: Safety surveillance of vaccines against COVID-19 is critical to ensure safety, maintain trust, and inform policy. ...EXPOSURES: Receipt of BNT162b2 (Pfizer-BioNTech) or mRNA-1273 (Moderna) COVID-19 vaccination, with a risk int …
IMPORTANCE: Safety surveillance of vaccines against COVID-19 is critical to ensure safety, maintain trust, and inform p …
Guillain-Barre Syndrome Associated with COVID-19 Vaccines: A Perspective From Spontaneous Report Data.
Atzenhoffer M, Auffret M, Pegat A, Masmoudi K, Khouri C, Bertin B, Vial T. Atzenhoffer M, et al. Clin Drug Investig. 2022 Jul;42(7):581-592. doi: 10.1007/s40261-022-01164-4. Epub 2022 Jun 9. Clin Drug Investig. 2022. PMID: 35676452 Free PMC article.
BACKGROUND AND OBJECTIVE: The concern surrounding the association between Guillain-Barre syndrome (GBS) and vaccination has increased with the widespread use of COVID-19 vaccines. ...CONCLUSIONS: These findings suggest both the absence of …
BACKGROUND AND OBJECTIVE: The concern surrounding the association between Guillain-Barre syndrome (GBS) and vaccination …
Risk of Guillain-Barre syndrome after COVID-19 vaccination or SARS-CoV-2 infection: A multinational self-controlled case series study.
Nasreen S, Jiang Y, Lu H, Lee A, Cutland CL, Gentile A, Giglio N, Macartney K, Deng L, Liu B, Sonneveld N, Bellamy K, Clothier HJ, Sepulveda Kattan G, Naus M, Naveed Z, Janjua NZ, Nguyen L, Hviid A, Poukka E, Perälä J, Leino T, Chandra LA, Thobari JA, Park BJ, Choi NK, Jeong NY, Madhi SA, Villalobos F, Solórzano M, Bissacco CA, Carreras-Martínez JJ, Correcher-Martínez E, Urchueguía-Fornes A, Roy D, Yeomans A, Aurelius T, Morton K, Di Mauro G, Sturkenboom MC, Sejvar JJ, Top KA, Batty K, Ghebreab L, Griffin JB, Petousis-Harris H, Buttery J, Black S, Kwong JC. Nasreen S, et al. Vaccine. 2025 Jul 11;60:127291. doi: 10.1016/j.vaccine.2025.127291. Epub 2025 May 28. Vaccine. 2025. PMID: 40440921 Free article.
BACKGROUND: The association between Guillain-Barre syndrome (GBS) and certain COVID-19 vaccines is inconclusive. We investigated the risk of GBS after COVID-19 vaccination or SARS-CoV-2 infection. ...CON …
BACKGROUND: The association between Guillain-Barre syndrome (GBS) and certain COVID-19 vaccines is inconc …
Guillain-Barre syndrome following COVID-19 vaccination: a study of 70 case reports.
Sah BK, Fatima Z, Sah RK, Syed B, Garg T, Chowdhury S, Ghosh B, Kunwar B, Shree A, Sah VK, Raut A. Sah BK, et al. Ann Med Surg (Lond). 2024 Mar 6;86(4):2067-2080. doi: 10.1097/MS9.0000000000001915. eCollection 2024 Apr. Ann Med Surg (Lond). 2024. PMID: 38576928 Free PMC article. Review.
BACKGROUND AND OBJECTIVE: Guillain-Barre syndrome (GBS) has been found to have some interesting association with vaccinations. ...CONCLUSION: Overall, this review evaluated innovative and clinically relevant associations between COVID-19 vacc …
BACKGROUND AND OBJECTIVE: Guillain-Barre syndrome (GBS) has been found to have some interesting association with vaccinatio …
Guillain-Barre Syndrome Following the mRNA COVID-19 Vaccination: Comment.
Mungmunpuntipantip R, Wiwanitkit V. Mungmunpuntipantip R, et al. Acta Neurol Taiwan. 2023 Dec 30;32(4):228-229. Acta Neurol Taiwan. 2023. PMID: 37781729 Free article.
Dear Editor, we would like to share ideas on the publication "Guillain-Barre Syndrome Following the BNT162b2 mRNA COVID-19 Vaccine [1]." In order to advance our understanding of this consequence, Algahtani et al. describe a case of Guillain …
Dear Editor, we would like to share ideas on the publication "Guillain-Barre Syndrome Following the BNT162b2 mRNA COVID …
Miller-Fisher syndrome and Guillain-Barre syndrome overlap syndrome following inactivated COVID-19 vaccine: Case report and scope review.
Liang H, Cao Y, Zhong W, Ma Z, Liu J, Chen H. Liang H, et al. Hum Vaccin Immunother. 2022 Nov 30;18(6):2125753. doi: 10.1080/21645515.2022.2125753. Epub 2022 Oct 31. Hum Vaccin Immunother. 2022. PMID: 36315834 Free PMC article. Review.
To the best of our knowledge, we report the first case of MFS-GBS overlap syndrome following the inactivated COVID-19 vaccination. However, a coincidental relationship with this inactivated vaccine cannot be excluded. Although the benefits of COVID …
To the best of our knowledge, we report the first case of MFS-GBS overlap syndrome following the inactivated COVID-19 vacci …
Reports of Guillain-Barre Syndrome After COVID-19 Vaccination in the United States.
Abara WE, Gee J, Marquez P, Woo J, Myers TR, DeSantis A, Baumblatt JAG, Woo EJ, Thompson D, Nair N, Su JR, Shimabukuro TT, Shay DK. Abara WE, et al. JAMA Netw Open. 2023 Feb 1;6(2):e2253845. doi: 10.1001/jamanetworkopen.2022.53845. JAMA Netw Open. 2023. PMID: 36723942 Free PMC article.
IMPORTANCE: Because of historical associations between vaccines and Guillain-Barre syndrome (GBS), the condition was a prespecified adverse event of special interest for COVID-19 vaccine monitoring. ...GBS case reports verified as meeting …
IMPORTANCE: Because of historical associations between vaccines and Guillain-Barre syndrome (GBS), the condition was a …
Guillain-Barre Syndrome and Variants Following COVID-19 Vaccination: Report of 13 Cases.
Kim JE, Min YG, Shin JY, Kwon YN, Bae JS, Sung JJ, Hong YH. Kim JE, et al. Front Neurol. 2022 Jan 27;12:820723. doi: 10.3389/fneur.2021.820723. eCollection 2021. Front Neurol. 2022. PMID: 35153993 Free PMC article.
BACKGROUND: Amidst growing concern about an increased risk of Guillain-Barre syndrome (GBS) following COVID-19 vaccination, clinical and electrodiagnostic features have not been fully characterized. ...RESULTS: We identified 13 patients with GBS …
BACKGROUND: Amidst growing concern about an increased risk of Guillain-Barre syndrome (GBS) following COVID-19 …
Guillain-Barre syndrome is infrequent among recipients of the BNT162b2 mRNA COVID-19 vaccine.
García-Grimshaw M, Michel-Chávez A, Vera-Zertuche JM, Galnares-Olalde JA, Hernández-Vanegas LE, Figueroa-Cucurachi M, Paredes-Ceballos O, Reyes-Terán G, Carbajal-Sandoval G, Ceballos-Liceaga SE, Arauz A, Valdés-Ferrer SI. García-Grimshaw M, et al. Clin Immunol. 2021 Sep;230:108818. doi: 10.1016/j.clim.2021.108818. Epub 2021 Aug 4. Clin Immunol. 2021. PMID: 34358692 Free PMC article.
Vaccines are the most effective strategy to mitigate the global impact of COVID-19. However, vaccine hesitancy is common, particularly among minorities. ...Our data suggest that, among recipients of the BNT162b2 mRNA vaccine, GBS may occur at th …
Vaccines are the most effective strategy to mitigate the global impact of COVID-19. However, vaccine hesitancy i …
Guillain-Barre syndrome following COVID-19 vaccine: A case report.
Fakhari MS, Poorsaadat L, Mahmoodiyeh B. Fakhari MS, et al. Clin Case Rep. 2022 Oct 13;10(10):e6451. doi: 10.1002/ccr3.6451. eCollection 2022 Oct. Clin Case Rep. 2022. PMID: 36254149 Free PMC article.
Coronavirus disease is a viral infection affecting different organs with various morbidities and mortality. Vaccines are used to control the disease. COVID-19 vaccines have brought many benefits but their adverse effects should not be ignored. Here, we …
Coronavirus disease is a viral infection affecting different organs with various morbidities and mortality. Vaccines are used to cont …
Guillain-Barre Syndrome following ChAdOx1-S/nCoV-19 Vaccine.
Maramattom BV, Krishnan P, Paul R, Padmanabhan S, Cherukudal Vishnu Nampoothiri S, Syed AA, Mangat HS. Maramattom BV, et al. Ann Neurol. 2021 Aug;90(2):312-314. doi: 10.1002/ana.26143. Epub 2021 Jun 22. Ann Neurol. 2021. PMID: 34114256
As of April 22, 2021, around 1.5 million individuals in three districts of Kerala, India had been vaccinated with COVID-19 vaccines. Over 80% of these individuals (1.2 million) received the ChAdOx1-S/nCoV-19 vaccine. In this population, during t …
As of April 22, 2021, around 1.5 million individuals in three districts of Kerala, India had been vaccinated with COVID-19 …
Guillain-Barre syndrome after COVID-19 vaccines: A Tunisian case series.
Berrim K, Lakhoua G, Zaiem A, Charfi O, Aouinti I, Kastalli S, Daghfous R, El Aidli S. Berrim K, et al. Br J Clin Pharmacol. 2023 Feb;89(2):574-578. doi: 10.1111/bcp.15601. Epub 2022 Nov 29. Br J Clin Pharmacol. 2023. PMID: 36398559 Free article.
As the COVID-19 vaccination campaign progresses worldwide, Guillain-Barre syndrome (GBS) vaccine-related cases have been reported. ...Our study aimed to identify epidemiological and clinical features of COVID-19 vaccine …
As the COVID-19 vaccination campaign progresses worldwide, Guillain-Barre syndrome (GBS) vaccine-r …
Association Between Guillain-Barre Syndrome and COVID-19 Infection and Vaccination: A Population-Based Nested Case-Control Study.
Bishara H, Arbel A, Barnett-Griness O, Bloch S, Cohen S, Najjar-Debbiny R, Gronich N, Auriel E, Saliba W. Bishara H, et al. Neurology. 2023 Nov 14;101(20):e2035-e2042. doi: 10.1212/WNL.0000000000207900. Epub 2023 Oct 18. Neurology. 2023. PMID: 37852786 Free PMC article.
The results were similar when exposure to SARS-CoV-2 infection or COVID-19 vaccine administration was ascertained in the prior 4 and 8 weeks, although did not reach statistical significance for COVID-19 vaccine at 4 w …
The results were similar when exposure to SARS-CoV-2 infection or COVID-19 vaccine administration …
Incidence of Guillain-Barre Syndrome (GBS) after COVID-19 Vaccination: a Systematic Review and Meta-Analysis.
Yazdani A, Mirmosayyeb O, Sadeghi M, Ghoshouni H, Tavakol G, Ghajarzadeh M. Yazdani A, et al. Maedica (Bucur). 2024 Jun;19(2):410-416. doi: 10.26574/maedica.2024.19.2.410. Maedica (Bucur). 2024. PMID: 39188850 Free PMC article. Review.
Guillain-Barre syndrome (GBS) is an acute immune-mediated inflammatory disease of the peripheral nerves (PNS) that is reported as a complication of both COVID-19 and vaccines. Up to now, case reports regarding the incidence of GBS have been repo …
Guillain-Barre syndrome (GBS) is an acute immune-mediated inflammatory disease of the peripheral nerves (PNS) that is reported …
Atypical Guillain-Barre Syndrome Presenting After COVID-19 Infection.
Noon A, Malhi JK, Wong CK. Noon A, et al. Cureus. 2022 Sep 24;14(9):e29521. doi: 10.7759/cureus.29521. eCollection 2022 Sep. Cureus. 2022. PMID: 36312645 Free PMC article.
Guillain-Barre syndrome (GBS) is an acute autoimmune disease affecting the peripheral nervous system presenting as a symmetric, ascending polyneuropathy. ...We present a case of a 46-year-old female with asymmetric ascending weakness, paresthesias, and acute onset u …
Guillain-Barre syndrome (GBS) is an acute autoimmune disease affecting the peripheral nervous system presenting as a symmetric …
Post COVID-19 vaccination Guillain-Barre syndrome: three cases.
Tabatabaee S, Rezania F, Alwedaie SMJ, Malekdar E, Badi Z, Tabatabaei SM, Mirzaasgari Z. Tabatabaee S, et al. Hum Vaccin Immunother. 2022 Nov 30;18(5):2045153. doi: 10.1080/21645515.2022.2045153. Epub 2022 Mar 3. Hum Vaccin Immunother. 2022. PMID: 35240922 Free PMC article.
Temporally associated cases of GBS following COVID-19 vaccination have been described with different COVID-19 vaccines. In this study, we report three cases of GBS patients following COVID-19 vaccine. ...All three pat …
Temporally associated cases of GBS following COVID-19 vaccination have been described with different COVID-19 …
Guillain-Barre syndrome following different COVID-19 vaccines: a case series.
Shalash A, Belal N, Zaki AS, Georgy SS, Doheim MF, Hazzou A, Abdelnasser A. Shalash A, et al. Egypt J Neurol Psychiatr Neurosurg. 2022;58(1):153. doi: 10.1186/s41983-022-00582-7. Epub 2022 Dec 9. Egypt J Neurol Psychiatr Neurosurg. 2022. PMID: 36532828 Free PMC article.
BACKGROUND: The COVID-19 vaccine-related Guillain-Barre syndrome (GBS) has been described for both messenger-RNA vaccine and adenovirus-vectored types in a few cases with great public concern and the necessity to inform physicians about t …
BACKGROUND: The COVID-19 vaccine-related Guillain-Barre syndrome (GBS) has been described for both messen …
Guillain-Barre syndrome after coronavirus disease 2019 vaccine: A temporal association.
da Silva GF, da Silva CF, Oliveira RENDN, Romancini F, Mendes RM, Locks A, Longo MFM, Moro CHC, Longo AL, Braatz VL. da Silva GF, et al. Clin Exp Neuroimmunol. 2022 May;13(2):92-94. doi: 10.1111/cen3.12678. Epub 2021 Oct 26. Clin Exp Neuroimmunol. 2022. PMID: 34900000 Free PMC article.
On rare occasions, people develop GBS after vaccination, but no causal association has been proven. In the current coronavirus disease 2019 (COVID-19) pandemic, some cases have been reported associating COVID-19 vaccine with GBS. ...It is …
On rare occasions, people develop GBS after vaccination, but no causal association has been proven. In the current coronavirus diseas …
Rehabilitation outcomes in patients with post-COVID-19 vaccine-associated Guillain-Barre syndrome.
Gupta A, Ranga A, Prakash NB, Khanna M. Gupta A, et al. J Neurosci Rural Pract. 2022 Oct-Dec;13(4):684-690. doi: 10.25259/JNRP-2022-6-26. Epub 2022 Dec 2. J Neurosci Rural Pract. 2022. PMID: 36743741 Free PMC article.
OBJECTIVE: With COVID-19 vaccination campaign worldwide, associated Guillain-Barre syndrome (GBS) is being increasingly reported from different countries. ...CONCLUSION: Comprehensive inpatient rehabilitation interventions in patients with post- …
OBJECTIVE: With COVID-19 vaccination campaign worldwide, associated Guillain-Barre syndrome (GBS) is bein …
Decreased Incidence of Guillain-Barre Syndrome during the COVID-19 Pandemic: A Retrospective Population-Based Study.
Hafsteinsdóttir B, Dalemo E, Elíasdóttir Ó, Ólafsson E, Axelsson M. Hafsteinsdóttir B, et al. Neuroepidemiology. 2023;57(1):1-6. doi: 10.1159/000527726. Epub 2022 Nov 10. Neuroepidemiology. 2023. PMID: 36366822 Free PMC article.
It has been suggested that both SARS-CoV-2 infection and vaccination may be triggering factors for Guillain-Barre syndrome, but evidence remains equivocal. ...Three cases were temporally associated with SARS-CoV-2 inf …
It has been suggested that both SARS-CoV-2 infection and vaccination may be triggering factors for Guillain …
COVID-19 Vaccination a Cause of Guillain-Barre Syndrome? A Case Series.
Nagdev G, Chavan G, Sahu G, Devasilpa Raju PD. Nagdev G, et al. Cureus. 2022 Oct 30;14(10):e30888. doi: 10.7759/cureus.30888. eCollection 2022 Oct. Cureus. 2022. PMID: 36465787 Free PMC article.
Viral infections like Zika virus, Epstein-Barr virus, and Cytomegalovirus also add to the list of GBS etiology. COVID-19 (SARS-CoV-2) has also been reported to cause GBS. Vaccines like the rabies vaccine, influenza vaccine, …
Viral infections like Zika virus, Epstein-Barr virus, and Cytomegalovirus also add to the list of GBS etiology. COVID-19 (S …
Impact of COVID-19 vaccination coverage on global disability burden of Guillain-Barre syndrome.
Gào X, Zhao C, Yang J, Yang Z, Feng J, Zhan S, Fan D, Liu Z. Gào X, et al. NPJ Vaccines. 2025 Aug 2;10(1):182. doi: 10.1038/s41541-025-01239-1. NPJ Vaccines. 2025. PMID: 40753095 Free PMC article.
The global burden of Guillain-Barre syndrome (GBS), an immune-mediated neuropathy, remains poorly characterized during the COVID-19 pandemic. ...Causal mediation analysis indicated that 44.6% of this association was mediated by reductions in COVID …
The global burden of Guillain-Barre syndrome (GBS), an immune-mediated neuropathy, remains poorly characterized during the …
[Case report of Guillain-Barre Syndrome after COVID BNT162b2 mRNA vaccine].
Sosa-Hernández O, Sánchez-Cardoza S. Sosa-Hernández O, et al. Vacunas. 2022 May;23:68-70. doi: 10.1016/j.vacun.2022.02.002. Epub 2022 May 2. Vacunas. 2022. PMID: 35528113 Free PMC article. Spanish.
CASE REPORT: We report the case of a 23-year-old male patient, a health student, who start 24 hours after received the second dose of COVID-19 vaccine, with proximal weakness of the right upper limb, later on the left side with descending and distal progressi …
CASE REPORT: We report the case of a 23-year-old male patient, a health student, who start 24 hours after received the second dose of COV …
Post-COVID-19 vaccine Guillain-Barre syndrome; first reported case from Qatar.
Razok A, Shams A, Almeer A, Zahid M. Razok A, et al. Ann Med Surg (Lond). 2021 Jul;67:102540. doi: 10.1016/j.amsu.2021.102540. Epub 2021 Jul 3. Ann Med Surg (Lond). 2021. PMID: 34249353 Free PMC article.
However, an association with the COVID-19 vaccine is yet to be established. PRESENTATION OF CASE: We present the case of an elderly gentleman with no history of SARS-CoV-2 infection or any recent viral or bacterial illnesses who presented …
However, an association with the COVID-19 vaccine is yet to be established. PRESENTATION OF CASE: We present the case o …
Guillain-Barre syndrome temporally associated with COVID-19 vaccines in Victoria, Australia.
Osowicki J, Morgan HJ, Harris A, Clothier HJ, Buttery JP, Kiers L, Crawford NW; SAEFVIC and VicSIS investigators. Osowicki J, et al. Vaccine. 2022 Dec 12;40(52):7579-7585. doi: 10.1016/j.vaccine.2022.10.084. Epub 2022 Nov 7. Vaccine. 2022. PMID: 36357291 Free PMC article.
Guillain-Barre syndrome (GBS) is an adverse event of special interest (AESI) for surveillance systems monitoring adverse events following immunisation (AEFI) with COVID-19 vaccines. Emerging data support a temporal association between GBS and ad …
Guillain-Barre syndrome (GBS) is an adverse event of special interest (AESI) for surveillance systems monitoring adverse event …
Guillain-Barre Syndrome After COVID-19 Infection in Korea: A Case Series.
Ryoo N, Son H, Kim JH, Bae DW, An JY. Ryoo N, et al. J Korean Med Sci. 2024 Feb 5;39(5):e48. doi: 10.3346/jkms.2024.39.e48. J Korean Med Sci. 2024. PMID: 38317448 Free PMC article.
Guillain-Barre syndrome (GBS) is an autoimmune-driven condition characterized by acute polyneuropathy, often emerging as a sequel to prior infections or vaccinations. This study presents the first reported cases of GBS emerging after the full recovery from co …
Guillain-Barre syndrome (GBS) is an autoimmune-driven condition characterized by acute polyneuropathy, often emerging as a seq …
Guillain-Barre Syndrome Followed by Covid-19 Infection, Vaccination and Other Precipitating Factors during the Pandemic.
Martic V, Fejzic E, Danilovic M, Lazarevic S, Rajic S, Roganovic M, Stojanov A, Jovin Z, Debeljevic M, Raicevic R. Martic V, et al. Ann Indian Acad Neurol. 2023 May-Jun;26(3):256-260. doi: 10.4103/aian.aian_974_22. Epub 2023 Apr 20. Ann Indian Acad Neurol. 2023. PMID: 37538436 Free PMC article.
The aim of this study was to notice GBS distinctness provoked by various triggers during the COVID-19 pandemic. MATERIAL AND METHODS: A total of 109 GBS patients were divided into three groups, respectively: COVID-19 infection associated (19 patients), …
The aim of this study was to notice GBS distinctness provoked by various triggers during the COVID-19 pandemic. MATERIAL AND M …
COVID-19, Guillain-Barre syndrome, and the vaccine. A dangerous combination.
Aomar-Millán IF, Martínez de Victoria-Carazo J, Peregrina-Rivas JA, Villegas-Rodríguez I. Aomar-Millán IF, et al. Rev Clin Esp (Barc). 2021 Nov;221(9):555-557. doi: 10.1016/j.rceng.2021.05.002. Epub 2021 Sep 27. Rev Clin Esp (Barc). 2021. PMID: 34593364 Free PMC article. No abstract available.
Rate of Recurrent Guillain-Barre Syndrome After mRNA COVID-19 Vaccine BNT162b2.
Shapiro Ben David S, Potasman I, Rahamim-Cohen D. Shapiro Ben David S, et al. JAMA Neurol. 2021 Nov 1;78(11):1409-1411. doi: 10.1001/jamaneurol.2021.3287. JAMA Neurol. 2021. PMID: 34468703 Free PMC article.
This study establishes rates of Guillain-Barre syndrome relapse among Pfizer-BioNTech BNT162b2 vaccine receivers....
This study establishes rates of Guillain-Barre syndrome relapse among Pfizer-BioNTech BNT162b2 vaccine receivers....
Guillain-Barre syndrome following COVID-19 vaccination: An updated systematic review of cases.
Shaheen N, Ramadan A, Nashwan AJ, Shaheen A, Ahmad S, Motawea KR, Mohamed S, Mohamed RS, Swed S, Aiash H. Shaheen N, et al. Clin Case Rep. 2023 Jun 7;11(6):e7456. doi: 10.1002/ccr3.7456. eCollection 2023 Jun. Clin Case Rep. 2023. PMID: 37305891 Free PMC article.
KEY CLINICAL MESSAGE: Guillain-Barre syndrome (GBS) is a rare but possible complication that may occur after COVID-19 vaccination. ...This systematic review reports 29 cases of GBS following COVID-19 vaccination, particularl …
KEY CLINICAL MESSAGE: Guillain-Barre syndrome (GBS) is a rare but possible complication that may occur after COVID-1 …
[Miller-Fisher/Guillain-Barre overlap syndrome following COVID-19 vaccination].
Atzin-Vela GA, Monroy-Parra CA, González-Rodríguez CH. Atzin-Vela GA, et al. Rev Med Inst Mex Seguro Soc. 2024 May 6;62(3):1-7. doi: 10.5281/zenodo.10998949. Rev Med Inst Mex Seguro Soc. 2024. PMID: 39530844 Free PMC article. Spanish.
BACKGROUND: Anti-GQ1B syndrome includes a group of diseases characterized by antibody-mediated polyneuropathy. Guillain Barre syndrome (GBS) and the Miller-Fisher syndrome (MFS) have been related to COVID-19 vaccine application. CLINIC CASE: 48- …
BACKGROUND: Anti-GQ1B syndrome includes a group of diseases characterized by antibody-mediated polyneuropathy. Guillain Barre …
Guillain-Barre syndrome after COVID-19 vaccination: A systematic review and analysis of case reports.
Abuawwad MT, Taha MJJ, Taha AJ, Kozaa YA, Falah O, Abuawwad IT, Hammad EM, Mahmoud AA, Aladawi M, Serhan HA. Abuawwad MT, et al. Clin Neurol Neurosurg. 2024 Mar;238:108183. doi: 10.1016/j.clineuro.2024.108183. Epub 2024 Feb 20. Clin Neurol Neurosurg. 2024. PMID: 38401232 Free article.
INTRODUCTION: Cases of Guillain-Barre Syndrome (GBS) have been believed to be associated with the novel COVID-19 infection, and also with the following vaccines developed against the infection. ...CONCLUSION: This work investigates the incidence …
INTRODUCTION: Cases of Guillain-Barre Syndrome (GBS) have been believed to be associated with the novel COVID-19 …
Could Guillain-Barre syndrome be triggered by COVID-19 vaccination?
Aldeeb M, Okar L, Mahmud SS, Adeli GA. Aldeeb M, et al. Clin Case Rep. 2022 Jan 18;10(1):e05237. doi: 10.1002/ccr3.5237. eCollection 2022 Jan. Clin Case Rep. 2022. PMID: 35079381 Free PMC article.
Due to SARS-COV-2 (COVID-19) pandemic and its catastrophic impact on society, the FDA granted emergency use authorization for some vaccines. ...We are reporting an elderly lady with multiple comorbidities who presented with progressive lo …
Due to SARS-COV-2 (COVID-19) pandemic and its catastrophic impact on society, the FDA granted emergency u …
Guillain-Barre Syndrome Post COVID-19 Vaccination with ChAdOx1 nCoV-19 Vaccine: A Colombian Case Report.
Hurtado IC, Vallejo-Serna R, Hurtado-Zapata JS, Misnaza SP. Hurtado IC, et al. Case Rep Infect Dis. 2023 Oct 11;2023:3290956. doi: 10.1155/2023/3290956. eCollection 2023. Case Rep Infect Dis. 2023. PMID: 37867584 Free PMC article.
BACKGROUND: Adverse events after vaccination against COVID-19 include rare events, such as Guillain-Barre syndrome. Study Aims. Documentation of clinical and temporary characteristics of the Guillain-Barre syndrome after using anti …
BACKGROUND: Adverse events after vaccination against COVID-19 include rare events, such as Guillain-Barre …
Case Series of Guillain-Barre Syndrome After the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) Vaccine.
Wan MM, Lee A, Kapadia R, Hahn C. Wan MM, et al. Neurol Clin Pract. 2022 Apr;12(2):149-153. doi: 10.1212/CPJ.0000000000001148. Neurol Clin Pract. 2022. PMID: 35747886 Free PMC article. Review.
PURPOSE OF REVIEW: Vaccination has been associated with Guillain-Barre syndrome (GBS). Amid a global vaccination campaign to stop the spread of COVID-19, fears of GBS can contribute to vaccine hesitancy. ...Neurologists should appr …
PURPOSE OF REVIEW: Vaccination has been associated with Guillain-Barre syndrome (GBS). Amid a global vaccination …
Infectious Neuropathies.
Boegle AK, Narayanaswami P. Boegle AK, et al. Continuum (Minneap Minn). 2023 Oct 1;29(5):1418-1443. doi: 10.1212/CON.0000000000001334. Continuum (Minneap Minn). 2023. PMID: 37851037
LATEST DEVELOPMENTS: Several infectious etiologies of peripheral neuropathy are well-recognized and their treatments are firmly established. The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is …
LATEST DEVELOPMENTS: Several infectious etiologies of peripheral neuropathy are well-recognized and their treatments are firmly established. …
A nationwide Guillain-Barre syndrome epidemiological study in Spain during the COVID-19 years.
Blanco-Ruiz M, Martín-Aguilar L, Caballero-Ávila M, Lleixà C, Pascual-Goñi E, Collet-Vidiella R, Tejada-Illa C, Turon-Sans J, Carbayo Á, Llansó L, Cortés E, Amaya Pascasio L, Querol L. Blanco-Ruiz M, et al. Eur J Neurol. 2024 Dec;31(12):e16439. doi: 10.1111/ene.16439. Epub 2024 Aug 12. Eur J Neurol. 2024. PMID: 39132887 Free PMC article.
Eleven per cent of GBS patients needed ventilatory support. GBS and SARS-CoV-2 incidences did not correlate with one another (r = -0.29, p = 0.36). GBS incidence decreased during 2020 and during the COVID-19 lockdown period in comparison to the …
Eleven per cent of GBS patients needed ventilatory support. GBS and SARS-CoV-2 incidences did not correlate with one an …
Neurological Complications of COVID-19: Guillain-Barre Syndrome Following Pfizer COVID-19 Vaccine.
Waheed S, Bayas A, Hindi F, Rizvi Z, Espinosa PS. Waheed S, et al. Cureus. 2021 Feb 18;13(2):e13426. doi: 10.7759/cureus.13426. Cureus. 2021. PMID: 33758714 Free PMC article.
Since the first case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was reported in Wuhan, China, in December 2019, Coronavirus - 19 (COVID-19) has become a global pandemic with multiple neurological complications. …
Since the first case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was reported in Wuhan, Chin …
COVID-19 vaccine causing Guillain-Barre syndrome, a rare potential side effect.
Matarneh AS, Al-Battah AH, Farooqui K, Ghamoodi M, Alhatou M. Matarneh AS, et al. Clin Case Rep. 2021 Aug 30;9(9):e04756. doi: 10.1002/ccr3.4756. eCollection 2021 Sep. Clin Case Rep. 2021. PMID: 34484780 Free PMC article.
Patients with neurological symptoms should be enquired about recent vaccination history. It is important after the COVID-19 mRNA vaccine, which is newly introduced as it might link to the development of a wider variety of neurological diseases....
Patients with neurological symptoms should be enquired about recent vaccination history. It is important after the COVID-19 …
Guillain-Barre syndrome after COVID-19 vaccination: report of two cases from Vietnam.
Hai PD, Phuong LL, Tot NH, Anh NLP, Tung ND, Quan NH. Hai PD, et al. J Infect Dev Ctries. 2022 Nov 29;16(11):1703-1705. doi: 10.3855/jidc.16998. J Infect Dev Ctries. 2022. PMID: 36449641 Free article.
Vaccines against COVID-19 are considered an essential measure to curb this pandemic. However, side effects, including local and systemic reactions, after administering the COVID-19 vaccine have been defined, and some side effects have bee …
Vaccines against COVID-19 are considered an essential measure to curb this pandemic. However, side effects, including l …
Guillain-Barre syndrome post-SARS-CoV-2 vaccine: a systematic review and data analysis on its clinical, laboratory, electrophysiological, and radiological features.
Hadhiah K, Alhashim A, Al-Dandan HA, Alhassan E, Alqarni AM, Memish AAA, Alabdali M. Hadhiah K, et al. Front Neurol. 2024 Jan 29;15:1332364. doi: 10.3389/fneur.2024.1332364. eCollection 2024. Front Neurol. 2024. PMID: 38352138 Free PMC article. Review.
The results favored the association between vector-based SARS-CoV-2 vaccine, particularly AstraZeneca vaccine, and the GBS. The mean of symptoms onset is 11.4 days. ...CONCLUSION: This study aimed to conduct a systematic review of reported cases …
The results favored the association between vector-based SARS-CoV-2 vaccine, particularly AstraZeneca vaccine …
Rare cases of Guillain-Barre syndrome after COVID-19 vaccination, Germany, December 2020 to August 2021.
Lehmann HC, Oberle D, Keller-Stanislawski B, Rieck T, Streit R. Lehmann HC, et al. Euro Surveill. 2023 Jun;28(24):2200744. doi: 10.2807/1560-7917.ES.2023.28.24.2200744. Euro Surveill. 2023. PMID: 37318764 Free PMC article.
Bilateral facial paresis was reported in 19.7% and 26.1% of the 156 GBS cases following vaccination with Vaxzevria and COVID-19 Vaccine Janssen, respectively, and only in 6% of cases exposed to Comirnaty.ConclusionThree and four times more GBS cases th …
Bilateral facial paresis was reported in 19.7% and 26.1% of the 156 GBS cases following vaccination with Vaxzevria and COVID- …
Sensory Ataxic Guillain-Barre Syndrome with Dysgeusia after mRNA COVID-19 Vaccination.
Ogata S, Ishii Y, Asano K, Kobayashi E, Kubota S, Takahashi K, Miyaji Y, Higashiyama Y, Joki H, Doi H, Koga M, Takeuchi H, Tanaka F. Ogata S, et al. Intern Med. 2022 Jun 1;61(11):1757-1760. doi: 10.2169/internalmedicine.8967-21. Epub 2022 Mar 26. Intern Med. 2022. PMID: 35342134 Free PMC article.
Guillain-Barre syndrome (GBS) has occasionally occurred in people who have received coronavirus disease 2019 (COVID-19) vaccines. ...Our report suggests that the COVID-19 vaccine may induce various clinical subtypes of GBS, …
Guillain-Barre syndrome (GBS) has occasionally occurred in people who have received coronavirus disease 2019 (COVID- …
Guillain-Barre syndrome after AstraZeneca COVID-19-vaccination: A causal or casual association?
Introna A, Caputo F, Santoro C, Guerra T, Ucci M, Mezzapesa DM, Trojano M. Introna A, et al. Clin Neurol Neurosurg. 2021 Sep;208:106887. doi: 10.1016/j.clineuro.2021.106887. Epub 2021 Aug 13. Clin Neurol Neurosurg. 2021. PMID: 34418708 Free PMC article.
We report a case of Guillain-Barre syndrome (GBS) following the first dose of Oxford/AstraZeneca COVID-19 vaccine with papilledema as atypical onset. As the COVID-19 vaccination campaign progresses worldwide, GBSs vaccine …
We report a case of Guillain-Barre syndrome (GBS) following the first dose of Oxford/AstraZeneca COVID-19 vac …
Onset of Guillain-Barre Syndrome and Transverse Myelitis Following COVID-19 Vaccination.
Do K, Kawana E, Do J, Diaz L. Do K, et al. Cureus. 2023 Jun 26;15(6):e41009. doi: 10.7759/cureus.41009. eCollection 2023 Jun. Cureus. 2023. PMID: 37519513 Free PMC article.
Guillain-Barre syndrome (GBS) and transverse myelitis (TM) are both neuro-inflammatory disorders that are attributed to dysfunctions of the peripheral nervous system and spinal cord, respectively. ...Although the incidence of GBS and TM is quite rare, there have bee …
Guillain-Barre syndrome (GBS) and transverse myelitis (TM) are both neuro-inflammatory disorders that are attributed to dysfun …
Risk of Guillain-Barre Syndrome Following COVID-19 Vaccines: A Nationwide Self-Controlled Case Series Study.
Le Vu S, Bertrand M, Botton J, Jabagi MJ, Drouin J, Semenzato L, Weill A, Dray-Spira R, Zureik M. Le Vu S, et al. Neurology. 2023 Nov 21;101(21):e2094-e2102. doi: 10.1212/WNL.0000000000207847. Epub 2023 Oct 3. Neurology. 2023. PMID: 37788935 Free PMC article.
BACKGROUND AND OBJECTIVES: Guillain-Barre syndrome (GBS) has been inconsistently associated with some coronavirus disease 2019 (COVID-19) vaccines. We aimed to quantify the risk of GBS according to the type of COVID-19 vaccine …
BACKGROUND AND OBJECTIVES: Guillain-Barre syndrome (GBS) has been inconsistently associated with some coronavirus disease 2019 …
A case of Guillain-Barre syndrome following Pfizer COVID-19 vaccine.
Rao SJ, Khurana S, Murthy G, Dawson ET, Jazebi N, Haas CJ. Rao SJ, et al. J Community Hosp Intern Med Perspect. 2021 Sep 20;11(5):597-600. doi: 10.1080/20009666.2021.1954284. eCollection 2021. J Community Hosp Intern Med Perspect. 2021. PMID: 34567447 Free PMC article.
We report the first case of Guillain-Barre Syndrome after receiving the second dose of the Pfizer COVID-19 vaccine, in a 42-year-old woman presenting with progressive ascending weakness and paresthesias. ...A longitudinal risk profile of neurolo …
We report the first case of Guillain-Barre Syndrome after receiving the second dose of the Pfizer COVID-19 va …
Is there a causal nexus between COVID-19 infection, COVID-19 vaccination, and Guillain-Barre syndrome?
Zheng X, Fang Y, Song Y, Liu S, Liu K, Zhu J, Wu X. Zheng X, et al. Eur J Med Res. 2023 Feb 25;28(1):98. doi: 10.1186/s40001-023-01055-0. Eur J Med Res. 2023. PMID: 36841799 Free PMC article. Review.
Especially, after the global outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, the causation between GBS and SARS-CoV-2 infection and the coronavirus disease 2019 (COVID-19) vaccin …
Especially, after the global outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, …
Guillain-Barre syndrome after mRNA-1273 (Moderna) COVID-19 vaccination: A case report.
Anjum Z, Iyer C, Naz S, Jaiswal V, Nepal G, Laguio-Vila M, Anandaram S, Thapaliya S. Anjum Z, et al. Clin Case Rep. 2022 Apr 14;10(4):e05733. doi: 10.1002/ccr3.5733. eCollection 2022 Apr. Clin Case Rep. 2022. PMID: 35441015 Free PMC article.
Guillain-Barre syndrome (GBS) is an acquired inflammatory polyradiculoneuropathy that often follows infection with a virus or bacteria and in rare occasions, vaccination may precede GBS. ...Though rare, this case report suggest that physician should remain vi …
Guillain-Barre syndrome (GBS) is an acquired inflammatory polyradiculoneuropathy that often follows infection with a virus or …
Reports of Guillain-Barre Syndrome Following COVID-19 Vaccination in the USA: An Analysis of the VAERS Database.
Chalela JA, Andrews C, Bashmakov A, Kapoor N, Snelgrove D. Chalela JA, et al. J Clin Neurol. 2023 Mar;19(2):179-185. doi: 10.3988/jcn.2022.0237. J Clin Neurol. 2023. PMID: 36854334 Free PMC article.
BACKGROUND AND PURPOSE: An association between Guillain-Barre syndrome and its variants (GBS/V) and vaccines has led to hesitancy toward vaccination. COVID-19 vaccines could theoretically provoke GBS/V via immune activation. We ana …
BACKGROUND AND PURPOSE: An association between Guillain-Barre syndrome and its variants (GBS/V) and vaccines has led to …
Rare occurrence of Guillain-Barre syndrome after Moderna vaccine.
Bijoy George T, Kainat A, Pachika PS, Arnold J. Bijoy George T, et al. BMJ Case Rep. 2022 May 9;15(5):e249749. doi: 10.1136/bcr-2022-249749. BMJ Case Rep. 2022. PMID: 35534045 Free PMC article.
No other antecedent event was identified other than receiving Moderna COVID-19 vaccine 4 weeks before the presentation and 3 days before symptom onset. CT head and CT angiogram of the head and neck were performed and demonstrated no acute intracranial bleedin …
No other antecedent event was identified other than receiving Moderna COVID-19 vaccine 4 weeks before the presentation …
Guillain-Barre syndrome following ChAdOx1 nCoV-19 COVID-19 vaccination: A case series.
James J, Jose J, Gafoor VA, Smita B, Balaram N. James J, et al. Neurol Clin Neurosci. 2021 Sep;9(5):402-405. doi: 10.1111/ncn3.12537. Epub 2021 Jul 21. Neurol Clin Neurosci. 2021. PMID: 34548920 Free PMC article.
ChAdOx1 nCoV-19 is an effective and well-tolerated coronavirus disease 2019 (COVID-19) vaccine. Rare cases of serious adverse events have been reported with this vaccine. We report three patients who developed Guillain-Barre syndrome foll …
ChAdOx1 nCoV-19 is an effective and well-tolerated coronavirus disease 2019 (COVID-19) vaccine. Rare cases of serious a …
Association between Guillain-Barre syndrome and SARS-CoV-2 virus infection, including the impact of COVID-19 vaccination in the context of the development and general clinical characteristics of the disease.
Sadowski J, Huk J, Otulak S, Zawiło J, Klaudel T, Roszak M, Tenczyński D, Bułdak RJ. Sadowski J, et al. J Neurovirol. 2025 Aug;31(4):333-346. doi: 10.1007/s13365-025-01267-6. Epub 2025 Jul 7. J Neurovirol. 2025. PMID: 40622507 Free PMC article.
This issue has been expanded to include information from studies on the impact of vaccination against SARS-CoV-2 virus and the higher number of observed cases of Guillain-Barre syndrome. ...It pointed out the molecular and clinical associ …
This issue has been expanded to include information from studies on the impact of vaccination against SARS-CoV-2 …
Guillain-Barre syndrome following the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases.
Bouattour N, Hdiji O, Sakka S, Fakhfakh E, Moalla K, Daoud S, Farhat N, Damak M, Mhiri C. Bouattour N, et al. Neurol Sci. 2022 Feb;43(2):755-761. doi: 10.1007/s10072-021-05733-x. Epub 2021 Nov 18. Neurol Sci. 2022. PMID: 34796417 Free PMC article.
Some studies have shown that neurological complications after COVID-19 vaccination are rare and dominated by demyelinating disease. CASE PRESENTATION: We present a case of a 67-year-old man who presented 7 days following his first dose of Pfizer-BioNTech C …
Some studies have shown that neurological complications after COVID-19 vaccination are rare and dominated by demyelinat …
Case Report: Post-COVID-19 Vaccine Recurrence of Guillain-Barre Syndrome Following an Antecedent Parainfectious COVID-19-Related GBS.
Bellucci M, Germano F, Grisanti S, Castellano C, Tazza F, Mobilia EM, Visigalli D, Novi G, Massa F, Rossi S, Durando P, Cabona C, Schenone A, Franciotta D, Benedetti L. Bellucci M, et al. Front Immunol. 2022 Jul 18;13:894872. doi: 10.3389/fimmu.2022.894872. eCollection 2022. Front Immunol. 2022. PMID: 35924236 Free PMC article.
We report on a unique combination of postcoronavirus disease 2019 (COVID-19) vaccine GBS that occurred months after a parainfectious COVID-19-related GBS. ...Future COVID-19 vaccinations/revaccinations in patients with previ …
We report on a unique combination of postcoronavirus disease 2019 (COVID-19) vaccine GBS that occurred months after a p …
Guillain-Barre syndrome: immunopathogenesis and therapeutic targets.
Liu S, Zhang WW, Jia L, Zhang HL. Liu S, et al. Expert Opin Ther Targets. 2024 Mar;28(3):131-143. doi: 10.1080/14728222.2024.2330435. Epub 2024 Mar 18. Expert Opin Ther Targets. 2024. PMID: 38470316 Review.
AREAS COVERED: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its vaccines as well as flaviviruses have been associated with GBS, although a robust conclusion has yet to be reached. ...EXPERT OPINION: The association with SA …
AREAS COVERED: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its vaccines as well as f …
RSV vaccines and Guillain-Barre syndrome: Insights into an emerging concern.
Anastassopoulou C, Panagiotopoulos AP, Ferous S, Poland GA, Dodick DW, Tsakris A. Anastassopoulou C, et al. Vaccine. 2025 Aug 13;61:127338. doi: 10.1016/j.vaccine.2025.127338. Epub 2025 Jun 3. Vaccine. 2025. PMID: 40466480 Review.
The recent approval of 3 different RSV vaccines marks a significant advancement in mitigating RSV-related morbidity and mortality. However, the increased incidence of Guillain-Barre syndrome (GBS) following RSV vaccination, confirmed by post-marketing …
The recent approval of 3 different RSV vaccines marks a significant advancement in mitigating RSV-related morbidity and mortality. Ho …
Recombinant protein subunit COVID-19 vaccine-induced Guillain-Barre Syndrome in an adolescent: A case report.
Rohilla R, Kakkar AK, Divyashree K, Mohindra R, Suri V. Rohilla R, et al. Br J Clin Pharmacol. 2023 Feb;89(2):556-560. doi: 10.1111/bcp.15466. Epub 2022 Aug 1. Br J Clin Pharmacol. 2023. PMID: 35856283 Free PMC article.
Guillain-Barre Syndrome (GBS), an autoimmune neurological disease of peripheral nerves, has been causally associated with COVID-19 vaccination in adults. ...The purpose of this report is to create awareness among health care professionals about …
Guillain-Barre Syndrome (GBS), an autoimmune neurological disease of peripheral nerves, has been causally associated with C …
Case of Guillain-Barre syndrome following COVID-19 vaccine.
Hasan T, Khan M, Khan F, Hamza G. Hasan T, et al. BMJ Case Rep. 2021 Jun 29;14(6):e243629. doi: 10.1136/bcr-2021-243629. BMJ Case Rep. 2021. PMID: 34187803 Free PMC article.
Guillain-Barre syndrome (GBS) is a rare immune-mediated disorder of the peripheral nerves. ...However, she had her first intramuscular dose of the Oxford/AstraZeneca COVID-19 vaccine 11 days prior to her presentation. Although no direct link cou …
Guillain-Barre syndrome (GBS) is a rare immune-mediated disorder of the peripheral nerves. ...However, she had her first intra …
[COVID-19, Guillain-Barre syndrome, and the vaccine. A dangerous combination].
Aomar-Millán IF, Martínez de Victoria-Carazo J, Peregrina-Rivas JA, Villegas-Rodríguez I. Aomar-Millán IF, et al. Rev Clin Esp. 2021 Nov;221(9):555-557. doi: 10.1016/j.rce.2021.05.005. Epub 2021 Jun 5. Rev Clin Esp. 2021. PMID: 34108736 Free PMC article. Spanish. No abstract available.
A Death for Guillain-Barre Syndrome After Receiving a COVID-19 Vaccine: A Case Report.
Coviello A, Iacovazzo C, Vargas M, Posillipo C, Sagnelli F, Diglio P, Cirillo D, Servillo G. Coviello A, et al. Clin Med Insights Case Rep. 2024 Oct 5;17:11795476241274692. doi: 10.1177/11795476241274692. eCollection 2024. Clin Med Insights Case Rep. 2024. PMID: 39377049 Free PMC article.
The virus SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) causes COVID-19, a potentially fatal disease. The COVID-19 vaccine is indicated for active immunization to prevent COVID-19 caused by SA …
The virus SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) causes COVID-19, a potentially fat …
Global burden of vaccine-associated Guillain-Barre syndrome over 170 countries from 1967 to 2023.
Jeong YD, Park S, Lee S, Jang W, Park J, Lee K, Lee J, Kang J, Udeh R, Rahmati M, Yeo SG, Smith L, Lee H, Yon DK. Jeong YD, et al. Sci Rep. 2024 Oct 19;14(1):24561. doi: 10.1038/s41598-024-74729-2. Sci Rep. 2024. PMID: 39427003 Free PMC article.
Most vaccines showed significant associations with GBS such as Ad5-vectored COVID-19 vaccines (ROR, 14.88; IC, 3.66), COVID-19 mRNA vaccines (ROR, 9.66; IC, 2.84), and inactivated whole-virus COVID-19 vaccines …
Most vaccines showed significant associations with GBS such as Ad5-vectored COVID-19 vaccines (ROR, 14.88; IC, 3 …
Guillain-Barre Syndrome: A Sequela of the Original COVID-19 Infection or Vaccination.
Ilyas U, Umar Z, Bhangal R, Shah D, Fayman B. Ilyas U, et al. Cureus. 2022 Aug 15;14(8):e28044. doi: 10.7759/cureus.28044. eCollection 2022 Aug. Cureus. 2022. PMID: 36127970 Free PMC article.
Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, many studies have reported the association between Guillain-Barre syndrome (GBS), COVID-19 infection, and vaccination. ...This case report sheds light on one …
Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, many studies have reported the association between …
Guillain-Barre Syndrome due to COVID-19 Vero Cell Vaccination Associated with Concomitant COVID-19 Infection-induced ARDS and Treated Successfully by Therapeutic Plasma Exchange: A First Case Report from Vietnam.
Duong-Quy S, Huynh-Truong-Anh D, Nguyen-Quang T, Nguyen-Thi-Kim T, Tran-Ngoc-Anh T, Nguyen-Van-Hoai N, Do-Thi-Thu M, Nguyen-Van T, Tang-Thi-Thao T, Nguyen-Tuan A, Nguyen-Van T, Tran-Xuan Q, Vu-Tran-Thien Q, Trinh-Du T, Tran-Thai T, Nguyen-Duy T, Tran-Van H, Vo-Thi-Kim A. Duong-Quy S, et al. Pulm Ther. 2023 Jun;9(2):271-280. doi: 10.1007/s41030-023-00219-x. Epub 2023 Mar 29. Pulm Ther. 2023. PMID: 36991236 Free PMC article.
In this article, we report a rare case of Guillain-Barre syndrome (GBS) in a patient with COVID-19 with acute respiratory distress syndrome (ARDS) after receiving Sinopharm's Vero Cell vaccine (China). ...Our report showed the potential of TPE f …
In this article, we report a rare case of Guillain-Barre syndrome (GBS) in a patient with COVID-19 with acute re …
Comparison of Guillain-Barre Syndrome Cases during and Prior to the COVID-19 Pandemic: A Multicentric Study.
Panicker P, R D, Gafoor AV, R PS, Iype T, Jose J, Stanley A. Panicker P, et al. J Assoc Physicians India. 2023 Sep;71(9):69-71. doi: 10.59556/japi.71.0317. J Assoc Physicians India. 2023. PMID: 38700304
BACKGROUND: Guillain-Barre syndrome (GBS) is one of the most common neurological manifestations associated with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. ...How to cite this article: Panicker P, R D, V AG, et …
BACKGROUND: Guillain-Barre syndrome (GBS) is one of the most common neurological manifestations associated with severe acute r …
SARS-CoV-2 vaccinations reduce the prevalence of post-COVID Guillain-Barre syndrome.
Finsterer J, Matovu D, Scorza FA. Finsterer J, et al. Clinics (Sao Paulo). 2022 Jun 13;77:100064. doi: 10.1016/j.clinsp.2022.100064. eCollection 2022. Clinics (Sao Paulo). 2022. PMID: 35751951 Free PMC article. Review.
Guillain-Barre Syndrome (GBS) has been repeatedly reported as a neurological complication of COVID-19 (post-COVID GBS [PCG]). ...It is concluded that the prevalence of PCG has decreased since the introduction of SARS-CoV-2 …
Guillain-Barre Syndrome (GBS) has been repeatedly reported as a neurological complication of COVID-19 (post-C …
Association of Receipt of the Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barre Syndrome, February-July 2021.
Woo EJ, Mba-Jonas A, Dimova RB, Alimchandani M, Zinderman CE, Nair N. Woo EJ, et al. JAMA. 2021 Oct 26;326(16):1606-1613. doi: 10.1001/jama.2021.16496. JAMA. 2021. PMID: 34617967 Free PMC article.
IMPORTANCE: As part of postauthorization safety surveillance, the US Food and Drug Administration (FDA) has identified a potential safety concern for Guillain-Barre syndrome (GBS) following receipt of the Ad26.COV2.S (Janssen/Johnson & Johnson) COVID-1 …
IMPORTANCE: As part of postauthorization safety surveillance, the US Food and Drug Administration (FDA) has identified a potential safety co …
Guillain-Barre Syndrome After Two COVID-19 Vaccinations: Two Case Reports With Follow-up Electrodiagnostic Study.
Kim JW, Kim YG, Park YC, Choi S, Lee S, Min HJ, Kim MJ. Kim JW, et al. J Korean Med Sci. 2022 Feb 21;37(7):e58. doi: 10.3346/jkms.2022.37.e58. J Korean Med Sci. 2022. PMID: 35191234 Free PMC article.
Following the severe acute respiratory syndrome-coronavirus-2 virus pandemic with co-introduction of massive vaccinations, several GBS cases associated with coronavirus disease 2019 (COVID-19) infection per se or after vaccination for COVID-1 …
Following the severe acute respiratory syndrome-coronavirus-2 virus pandemic with co-introduction of massive vaccinations, several GB …
Guillain-Barre Syndrome After COVID-19 Vaccination: A Secondary Analysis of Domestic Safety Data by the Japanese Government.
Kaneda Y, Hashimoto T, Kaneda U, Higuchi Y, Murakami J, Inada M, Senoo Y, Fujieda T, Murata Y, Tanimoto T. Kaneda Y, et al. Cureus. 2022 Oct 31;14(10):e30905. doi: 10.7759/cureus.30905. eCollection 2022 Oct. Cureus. 2022. PMID: 36337786 Free PMC article.
Purpose The purpose of this study was to figure out the risk of Guillain-Barre syndrome (GBS) after coronavirus disease 2019 (COVID-19) vaccination, which has been reported as a rare adverse reaction. ...The estimated incidence was about 0.0001% …
Purpose The purpose of this study was to figure out the risk of Guillain-Barre syndrome (GBS) after coronavirus disease 2019 ( …
Neurologic Sequela of COVID-19: Guillain-Barre Syndrome Following Johnson & Johnson COVID-19 Vaccination.
Carranza O, Babici D, Waheed S, Yousuf F. Carranza O, et al. Cureus. 2022 Apr 18;14(4):e24252. doi: 10.7759/cureus.24252. eCollection 2022 Apr. Cureus. 2022. PMID: 35602794 Free PMC article.
Guillain-Barre syndrome after Pfizer and Astra-Zeneca vaccinations against COVID-19 has been previously reported in the literature. The objective of this study was to report the first case of Guillain-Barre following the COVID …
Guillain-Barre syndrome after Pfizer and Astra-Zeneca vaccinations against COVID-19 has been previously r …
Intractable Neuropathic Pain in COVID-19-Induced Guillain-Barre Syndrome: A Case Report.
Ritter S, Gable D, May A, Darwish Y, Friedlander T. Ritter S, et al. Cureus. 2023 Mar 20;15(3):e36426. doi: 10.7759/cureus.36426. eCollection 2023 Mar. Cureus. 2023. PMID: 37090295 Free PMC article.
There is limited literature specific to neuropathic pain in coronavirus disease 2019 (COVID-19)-induced acute inflammatory demyelinating polyneuropathy (AIDP). We present a unique case of a 20-year-old vaccinated female with a past medical history of chronic …
There is limited literature specific to neuropathic pain in coronavirus disease 2019 (COVID-19)-induced acute inflammatory dem …
Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: Report of two cases and review of literature.
Min YG, Ju W, Ha YE, Ban JJ, Lee SA, Sung JJ, Shin JY. Min YG, et al. J Neuroimmunol. 2021 Oct 15;359:577691. doi: 10.1016/j.jneuroim.2021.577691. Epub 2021 Aug 8. J Neuroimmunol. 2021. PMID: 34416410 Free PMC article. Review.
Massive vaccination against COVID-19 has become a global priority. Simultaneously, concerns regarding the safety of vaccines are growing. We describe two patients who developed sensory Guillain-Barre syndrome (GBS) shortly after the first …
Massive vaccination against COVID-19 has become a global priority. Simultaneously, concerns regarding the safety of …
Impact of COVID-19 on Guillain Barre Syndrome (GBS) insights from an Iranian referral center.
Arami M, Manteghifasaei R, Karimi M, Zandi P, Javadi M. Arami M, et al. Front Neurol. 2025 May 7;16:1565912. doi: 10.3389/fneur.2025.1565912. eCollection 2025. Front Neurol. 2025. PMID: 40401018 Free PMC article.
BACKGROUND: The COVID-19 pandemic has raised concerns about various neurological complications, including Guillain-Barre syndrome (GBS). ...Characteristics of COVID-19 associated GBS and those vaccinated for COVID-19 …
BACKGROUND: The COVID-19 pandemic has raised concerns about various neurological complications, including Guillain-B …
To be, or not to be Guillain-Barre Syndrome.
Florian IA, Lupan I, Sur L, Samasca G, Timiș TL. Florian IA, et al. Autoimmun Rev. 2021 Dec;20(12):102983. doi: 10.1016/j.autrev.2021.102983. Epub 2021 Oct 28. Autoimmun Rev. 2021. PMID: 34718164 Review.
Guillain-Barre Syndrome (GBS) is currently the most frequent cause of acute flaccid paralysis on a global scale, being an autoimmune disorder wherein demyelination of the peripheral nerves occurs. ...GBS most commonly occurs after an infection, especially viral (inc …
Guillain-Barre Syndrome (GBS) is currently the most frequent cause of acute flaccid paralysis on a global scale, being an auto …
No significant increase in Guillain-Barre syndrome after COVID-19 vaccination in adults: A vaccine adverse event reporting system study.
Jaffry M, Mostafa F, Mandava K, Rosario S, Jagarlamudi Y, Jaffry K, Kornitzer J, Jedidi K, Khan H, Souayah N. Jaffry M, et al. Vaccine. 2022 Sep 22;40(40):5791-5797. doi: 10.1016/j.vaccine.2022.08.038. Epub 2022 Aug 22. Vaccine. 2022. PMID: 36055875 Free PMC article.
OBJECTIVE: To investigate the association between Guillain-Barre syndrome (GBS) and COVID-19 vaccination. BACKGROUND: On July 13, 2021, the US Food and Drug Administration (FDA) released a new warning that Johnson & Johnson COVID- …
OBJECTIVE: To investigate the association between Guillain-Barre syndrome (GBS) and COVID-19 vaccination. …
Vaccine-Induced Functional Neurological Disorders in the Covid-19 Era.
de Souza A, Jacques R, Mohan S. de Souza A, et al. Can J Neurol Sci. 2023 May;50(3):346-350. doi: 10.1017/cjn.2022.48. Epub 2022 Apr 25. Can J Neurol Sci. 2023. PMID: 35466898 Review.
The large amount of information available to the public regarding vaccines against Covid-19 coupled with pandemic stress and increased somatic attention could potentially precipitate development of functional neurological disorders (FNDs) following vaccina …
The large amount of information available to the public regarding vaccines against Covid-19 coupled with pandemic stres …
Neuroimaging of COVID-19.
Kim J, Young GS. Kim J, et al. Semin Neurol. 2023 Apr;43(2):205-218. doi: 10.1055/s-0043-1767771. Epub 2023 Jun 28. Semin Neurol. 2023. PMID: 37379850 Review.
We review the wide variety of common neuroimaging manifestations related to coronavirus disease 2019 (COVID-19) and COVID therapies, grouping the entities by likely pathophysiology, recognizing that the etiology of many entities remains uncertain. ...Later po …
We review the wide variety of common neuroimaging manifestations related to coronavirus disease 2019 (COVID-19) and COVID …
SARS-CoV-2 vaccination triggered Guillain-Barre syndrome.
Scorza FA, Finsterer J. Scorza FA, et al. Clin Neurol Neurosurg. 2022 Feb;213:107106. doi: 10.1016/j.clineuro.2021.107106. Epub 2021 Dec 29. Clin Neurol Neurosurg. 2022. PMID: 34974378 Free PMC article. No abstract available.
Guillain-Barre Syndrome Presenting as Facial Diplegia after COVID-19 Vaccination: A Case Report.
Rossetti A, Gheihman G, O'Hare M, Kosowsky JM. Rossetti A, et al. J Emerg Med. 2021 Dec;61(6):e141-e145. doi: 10.1016/j.jemermed.2021.07.062. Epub 2021 Aug 7. J Emerg Med. 2021. PMID: 34538679 Free PMC article.
BACKGROUND: Guillain-Barre Syndrome (GBS) is a rapidly progressive immune-mediated polyneuropathy often associated with an antecedent infectious illness or vaccination. ...This may be of particular importance in the context of a worldwide vaccination c …
BACKGROUND: Guillain-Barre Syndrome (GBS) is a rapidly progressive immune-mediated polyneuropathy often associated with an ant …
Exacerbating Guillain-Barre Syndrome Eight Days after Vector-Based COVID-19 Vaccination.
Finsterer J. Finsterer J. Case Rep Infect Dis. 2021 May 8;2021:3619131. doi: 10.1155/2021/3619131. eCollection 2021. Case Rep Infect Dis. 2021. PMID: 34055430 Free PMC article.
Exacerbation of Guillain-Barre syndrome (GBS) shortly after COVID-19 vaccination has not been communicated. ...Although apparently extremely rare, neurologists should remain vigilant for a potential recurrence of GBS after vaccination wit …
Exacerbation of Guillain-Barre syndrome (GBS) shortly after COVID-19 vaccination has not been communicate …
Guillain-Barre Syndrome After Ad26.COV2.S Vaccination.
Thant HL, Morgan R, Paese MM, Persaud T, Diaz J, Hurtado L. Thant HL, et al. Am J Case Rep. 2022 Feb 14;23:e935275. doi: 10.12659/AJCR.935275. Am J Case Rep. 2022. PMID: 35157644 Free PMC article.
BACKGROUND Since December 2020, multiple vaccines have mobilized mass immunization campaigns capable of mitigating the current SARS-COV-2 pandemic. Ad26.COV2.S (Johnson & Johnson/Janssen) is a recombinant, replication-incompetent vector vaccine …
BACKGROUND Since December 2020, multiple vaccines have mobilized mass immunization campaigns capable of mitigating the current SAR …
Guillain-Barre syndrome (GBS) after severe/critical COVID-19 or COVID-19 vaccination.
Bahrami S, Ansari B, Norouzi-Barough L, Bagherpour B, Khorvash F, Shirani K, Abbasi S, Sherkat R. Bahrami S, et al. Eur J Med Res. 2025 Feb 24;30(1):131. doi: 10.1186/s40001-025-02378-w. Eur J Med Res. 2025. PMID: 39994747 Free PMC article.
Neurological manifestations have been reported in more than one-third of COVID-19 patients, particularly in severe instances. While vaccines are pivotal in combating infectious diseases and enhancing public health, reports have linked Guillain-Barre …
Neurological manifestations have been reported in more than one-third of COVID-19 patients, particularly in severe instances. …
Guillain-Barre syndrome following the second dose of COVID AstraZeneca vaccine in a 78-year-old male: a case report from Nepal.
Acharya B, Kc S, Karki S, Thapa P, Kc P. Acharya B, et al. Ann Med Surg (Lond). 2023 Feb 17;85(3):466-469. doi: 10.1097/MS9.0000000000000193. eCollection 2023 Mar. Ann Med Surg (Lond). 2023. PMID: 36923770 Free PMC article.
The robust causal relationships between COVID-19 infections, COVID-19 vaccination, and GBS are still unclear. The evaluation of the potential association and risk of GBS with vaccines warrants the need for precise post-vaccination …
The robust causal relationships between COVID-19 infections, COVID-19 vaccination, and GBS are still uncl …
Scrutinizing the COVID-19 vaccine safety debate.
Bin Abdulrahman K, Bin Abdulrahman A. Bin Abdulrahman K, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2401646. doi: 10.1080/21645515.2024.2401646. Epub 2024 Oct 29. Hum Vaccin Immunother. 2024. PMID: 39693192 Free PMC article.
A 2024 multinational study in the journal Vaccine presented preexisting safety indicators for myocarditis, pericarditis, Guillain - Barre syndrome, and cerebral venous sinus thrombosis. ...The controversy surrounding COVID-19 vaccine safe …
A 2024 multinational study in the journal Vaccine presented preexisting safety indicators for myocarditis, pericarditis, Guillain …
Guillain-Barre syndrome presenting with facial diplegia following COVID-19 vaccination in two patients.
Kanabar G, Wilkinson P. Kanabar G, et al. BMJ Case Rep. 2021 Oct 14;14(10):e244527. doi: 10.1136/bcr-2021-244527. BMJ Case Rep. 2021. PMID: 34649856 Free PMC article.
In March 2020, the WHO declared COVID-19 to be a global pandemic and since December 2020, millions of vaccines have been administered. To date, cases of Guillain-Barre syndrome (GBS) following a COVID vaccine (Pfizer, Johnson & …
In March 2020, the WHO declared COVID-19 to be a global pandemic and since December 2020, millions of vaccines have bee …
A Rare Case of Guillain-Barre Syndrome following COVID-19 Vaccination.
Kripalani Y, Lakkappan V, Parulekar L, Shaikh A, Singh R, Vyas P. Kripalani Y, et al. Eur J Case Rep Intern Med. 2021 Sep 14;8(9):002707. doi: 10.12890/2021_002797. eCollection 2021. Eur J Case Rep Intern Med. 2021. PMID: 34671572 Free PMC article.
Various vaccines against COVID-19 have been developed since SARS-CoV-2 emerged at the end of 2019. ...LEARNING POINTS: Guillain-Barre Syndrome (GBS) is a very rare complication after vaccination against SARS- …
Various vaccines against COVID-19 have been developed since SARS-CoV-2 emerged at the end of 2019. …
Guillain-Barre syndrome in an era of global infections and 21st century vaccination.
Lunn MP. Lunn MP. Curr Opin Neurol. 2022 Oct 1;35(5):571-578. doi: 10.1097/WCO.0000000000001086. Epub 2022 Jul 18. Curr Opin Neurol. 2022. PMID: 36069416 Review.
The severe acute respiratory syndrome coronavirus 2 (Sars-CoV-2) pandemic and the worldwide immunization programme provoked fears of an epidemic of coronavirus disease 2019 (COVID-19) related disease. As we emerge from the pandemic this r …
The severe acute respiratory syndrome coronavirus 2 (Sars-CoV-2) pandemic and the worldwide immunization program …
The Impact of COVID-19 and Vaccine on the Human Nervous System.
Chen F, Cao P, Liu H, Cai D. Chen F, et al. Neuroendocrinology. 2022;112(11):1046-1057. doi: 10.1159/000524234. Epub 2022 Mar 22. Neuroendocrinology. 2022. PMID: 35316815 Free PMC article. Review.
The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has precipitated a global health crisis of unprecedented proportions. ...Particularly, previous vaccination campaigns …
The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV …
COVID-19 vaccine safety: Background incidence rates of anaphylaxis, myocarditis, pericarditis, Guillain-Barre Syndrome, and mortality in South Korea using a nationwide population-based cohort study.
Jeong HS, Chun BC. Jeong HS, et al. PLoS One. 2024 Feb 21;19(2):e0297902. doi: 10.1371/journal.pone.0297902. eCollection 2024. PLoS One. 2024. PMID: 38381729 Free PMC article.
Therefore, in this study, we estimated the background incidence of anaphylaxis, myocarditis, pericarditis, Guillain-Barre syndrome (GBS), and mortality in South Korea. METHODS: A retrospective cohort study was conducted using the National Sample Cohort (NSC) data. . …
Therefore, in this study, we estimated the background incidence of anaphylaxis, myocarditis, pericarditis, Guillain-Barre synd …
Guillain-Barre Syndrome Following the First Dose of Inactivated SARS-CoV-2 Vaccine, BBIBP-CorV.
Wijekoon L, Sarathchandra C, Siribaddana S. Wijekoon L, et al. Cureus. 2023 Jan 18;15(1):e33952. doi: 10.7759/cureus.33952. eCollection 2023 Jan. Cureus. 2023. PMID: 36819409 Free PMC article.
We present a case report of Guillain-Barre syndrome (GBS) following inactivated whole virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine, BBIBP-CorV. ...Clinicians need to be aware of the possibility of GBS …
We present a case report of Guillain-Barre syndrome (GBS) following inactivated whole virus severe acute respiratory syndrome …
Guillain-Barre syndrome following the first dose of the chimpanzee adenovirus-vectored COVID-19 vaccine, ChAdOx1.
Patel SU, Khurram R, Lakhani A, Quirk B. Patel SU, et al. BMJ Case Rep. 2021 Apr 22;14(4):e242956. doi: 10.1136/bcr-2021-242956. BMJ Case Rep. 2021. PMID: 33888484 Free PMC article.
Prevention strategies for COVID-19 transmission are at the forefront of healthcare paradigms worldwide, the main emphasis of which is vaccination. ...He also had a negative COVID-19 swab during admission. A diagnosis of Guillain-Barre …
Prevention strategies for COVID-19 transmission are at the forefront of healthcare paradigms worldwide, the main emphasis of w …
Neurolymphomatosis mimicking a Guillain-Barre syndrome triggered by COVID-19 vaccination.
Colombo D, Falasca L, Monardo F, D'Ambrosio M, Di Napoli A, Salerno A, Del Nonno F, Comanducci G. Colombo D, et al. Neuropathology. 2025 Feb;45(1):76-82. doi: 10.1111/neup.13003. Epub 2024 Sep 23. Neuropathology. 2025. PMID: 39311044 Free PMC article.
Guillain-Barre syndrome (GBS) is an acute disorder of the peripheral nervous system, causing flaccid paralysis, areflexia, and variable sensory involvement. ...Here we present a case of a 36-year-old man hospitalized for acute polyradiculoneuritis of the cranial ner …
Guillain-Barre syndrome (GBS) is an acute disorder of the peripheral nervous system, causing flaccid paralysis, areflexia, and …
Experience of treatment in critical Guillain-Barre Syndrome case after COVID-19 vaccination.
Zhu C, Wang H, Zhang Y, Wang W, Wang J, Li W. Zhu C, et al. Int J Dev Neurosci. 2024 Jun;84(4):342-348. doi: 10.1002/jdn.10325. Epub 2024 Apr 8. Int J Dev Neurosci. 2024. PMID: 38590219
BACKGROUND: The current study reported a case with a history of neuroradiculitis. Within 2 months of the COVID-19 vaccine, critical Guillain-Barre Syndrome (GBS) appeared after acute diarrhea, progressive myasthenia, and sudden respiratory and c …
BACKGROUND: The current study reported a case with a history of neuroradiculitis. Within 2 months of the COVID-19 vaccine …
Vaccine hesitancy with a history of Guillain Barre Syndrome: Weighing the risks and benefits of SARS-CoV-2 vaccination.
Murawska Baptista A, Alok A, Libertin C. Murawska Baptista A, et al. IDCases. 2022 Mar 5;28:e01467. doi: 10.1016/j.idcr.2022.e01467. eCollection 2022. IDCases. 2022. PMID: 35284232 Free PMC article.
The most striking adverse events reported include thrombosis with thrombocytopenia syndrome (TTS), myocarditis, and Guillain Barre Syndrome (GBS). Post-vaccination GBS is known since the time of Influenza vaccination, but several cases of GBS have also …
The most striking adverse events reported include thrombosis with thrombocytopenia syndrome (TTS), myocarditis, and Guillain Barre …
Neurological Complications Following COVID-19 Vaccination.
Chatterjee A, Chakravarty A. Chatterjee A, et al. Curr Neurol Neurosci Rep. 2023 Jan;23(1):1-14. doi: 10.1007/s11910-022-01247-x. Epub 2022 Nov 29. Curr Neurol Neurosci Rep. 2023. PMID: 36445631 Free PMC article. Review.
PURPOSE OF REVIEW: A variety of neurological complications have been reported following the widespread use of the COVID-19 vaccines which may lead to vaccine hesitancy and serve as a major barrier to the public health aim of achieving protective herd i …
PURPOSE OF REVIEW: A variety of neurological complications have been reported following the widespread use of the COVID-19 …
[A Patient Developing Guillain-Barre Syndrome After Receiving the BNT162b2 COVID-19 mRNA Vaccine].
Oshibe N, Honda M, Koga M, Sato R, Oishi M, Kanda T. Oshibe N, et al. Brain Nerve. 2022 Aug;74(8):1025-1030. doi: 10.11477/mf.1416202173. Brain Nerve. 2022. PMID: 35941801 Japanese.
We report a 71-year-old woman who presented with paresthesia, progressive weakness, difficulty walking, diarrhea, and bladder dysfunction one week after she received the BNT162b2 COVID-19 vaccine. Her neurological signs and symptoms gradually worsened up to 2 …
We report a 71-year-old woman who presented with paresthesia, progressive weakness, difficulty walking, diarrhea, and bladder dysfunction on …
COVID-19 Vaccination in Korea.
Park WB, Hwang YH, Cheong HJ. Park WB, et al. Infect Chemother. 2023 Mar;55(1):135-149. doi: 10.3947/ic.2023.0023. Infect Chemother. 2023. PMID: 37021429 Free PMC article. Review.
COVID-19 vaccination can effectively reduce hospitalization and deaths due to symptomatic COVID-19, especially severe and critical COVID-19. ...The indications and schedule for COVID-19 vaccination are subject …
COVID-19 vaccination can effectively reduce hospitalization and deaths due to symptomatic COVID-19, espec …
Guillain-Barre Syndrome and Unilateral Optic Neuritis Following Vaccination for COVID-19: A Case Report and Literature Review.
Richardson-May J, Purcaru E, Campbell C, Hillier C, Parkin B. Richardson-May J, et al. Neuroophthalmology. 2022 May 23;46(6):413-419. doi: 10.1080/01658107.2022.2048861. eCollection 2022. Neuroophthalmology. 2022. PMID: 36544589 Free PMC article.
A 71-year-old woman presented 2 weeks after vaccination with the first dose of Vaxzevria (AstraZeneca, Oxford) for COVID-19 with a left lower motor neuron facial nerve palsy, which progressed to bilateral involvement. ...She was diagnosed with the 'facial dip …
A 71-year-old woman presented 2 weeks after vaccination with the first dose of Vaxzevria (AstraZeneca, Oxford) for COVID-19 …
Guillain-Barre syndrome (GBS) associated with COVID-19 infection that resolved without treatment in a child.
Kanou S, Wardeh L, Govindarajan S, Macnay K. Kanou S, et al. BMJ Case Rep. 2022 Mar 10;15(3):e245455. doi: 10.1136/bcr-2021-245455. BMJ Case Rep. 2022. PMID: 35272988 Free PMC article.
The brain and spine MRI with contrast illustrated abnormal enhancement-suggestive of Guillain-Barre syndrome.The case had limited distribution and it did not progress beyond the presenting clinical involvements. ...
The brain and spine MRI with contrast illustrated abnormal enhancement-suggestive of Guillain-Barre syndrome.The case had limi …
Exploring the adverse events of Oxford-AstraZeneca, Pfizer-BioNTech, Moderna, and Johnson and Johnson COVID-19 vaccination on Guillain-Barre Syndrome.
Meo SA, Shaikh N, Abukhalaf FA, Meo AS. Meo SA, et al. Sci Rep. 2024 Aug 13;14(1):18767. doi: 10.1038/s41598-024-66999-7. Sci Rep. 2024. PMID: 39138276 Free PMC article.
The vaccination against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is an important public health strategy to prevent people from the pandemic. ...In this study, initially 128 documents were identified from the databases, includ …
The vaccination against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is an important publ …
Guillain-Barre Syndrome Following Moderna Spikevax Messenger RNA COVID-19 Vaccine: A Case Analysis.
Aldakkour JL, Newman-Caro AB, Bardan U, Gonzalez-Montalvo H, Ramamurthy G. Aldakkour JL, et al. HCA Healthc J Med. 2025 Apr 1;6(2):163-166. doi: 10.36518/2689-0216.1512. eCollection 2025. HCA Healthc J Med. 2025. PMID: 40386749 Free PMC article.
BACKGROUND: Guillain-Barre Syndrome (GBS) is an acute autoimmune polyneuropathy. Cases of GBS have been reported following administration of the vaccines for swine influenza, seasonal influenza, hemagglutinin type 1 and neuraminidase type 1, and meningococcal …
BACKGROUND: Guillain-Barre Syndrome (GBS) is an acute autoimmune polyneuropathy. Cases of GBS have been reported following adm …
Neurological Consequences of COVID-19: A Curious Case of Delayed Onset Guillain-Barre.
Devarakonda AK, Stumpe TR, Saucier AN, Riley T. Devarakonda AK, et al. Cureus. 2022 May 25;14(5):e25325. doi: 10.7759/cureus.25325. eCollection 2022 May. Cureus. 2022. PMID: 35761907 Free PMC article.
SARS-CoV-2 is responsible for causing the COVID-19 pandemic and over 4 million deaths globally. ...Here, we present an interesting case of GBS in a patient with a previous COVID-19 infection. A 63-year-old male with a past medical …
SARS-CoV-2 is responsible for causing the COVID-19 pandemic and over 4 million deaths globally. ...Here, …
Bilateral facial palsy with paresthesias, variant of Guillain-Barre syndrome following COVID-19 vaccine: A case series of 9 patients.
Castiglione JI, Crespo JM, Lecchini L, Silveira FO, Luis MB, Cotti N, Simison CJ, Aguirre F, Piedrabuena MA, Alonso RN, Azcona CL, Sosa PS, Maldonado E, Barroso F. Castiglione JI, et al. Neuromuscul Disord. 2022 Jul;32(7):572-574. doi: 10.1016/j.nmd.2022.05.003. Epub 2022 May 11. Neuromuscul Disord. 2022. PMID: 35644722 Free PMC article.
Several cases of Guillain-Barre Syndrome (GBS) associated with COVID-19 vaccination have been reported, including the rare subtype known as Bilateral Facial Palsy with paresthesias (BFP). ...Seven patients received intravenous immunoglobulin tre …
Several cases of Guillain-Barre Syndrome (GBS) associated with COVID-19 vaccination have been reported, i …
The impact of the COVID-19 pandemic on the incidence and clinical profiles of Guillain-Barre syndrome in Japan.
Suichi T, Misawa S, Ukita S, Shibuya K, Ogushi M, Sato Y, Kuwabara S. Suichi T, et al. Brain. 2026 Apr 22:awag144. doi: 10.1093/brain/awag144. Online ahead of print. Brain. 2026. PMID: 42025320 Free article.
Since the coronavirus disease 2019 (COVID-19) pandemic began in 2020, several studies from various countries have described changes in the epidemiology of Guillain-Barre syndrome (GBS); however, it remains unclear whether the incidence and clinical pro …
Since the coronavirus disease 2019 (COVID-19) pandemic began in 2020, several studies from various countries have described ch …
Bilateral Facial Weakness with Distal Paresthesia Following COVID-19 Vaccination: A Scoping Review for an Atypical Variant of Guillain-Barre Syndrome.
Kim YH, Kim JE, Yoon BA, Kim JK, Bae JS. Kim YH, et al. Brain Sci. 2022 Aug 7;12(8):1046. doi: 10.3390/brainsci12081046. Brain Sci. 2022. PMID: 36009109 Free PMC article.
Background and Purpose: Recent population-based studies from the US and UK have identified an increase in the occurrence of Guillain-Barre syndrome (GBS) following coronavirus disease 2019 (COVID-19) vaccination. ...In contrast, facial nerve enh …
Background and Purpose: Recent population-based studies from the US and UK have identified an increase in the occurrence of Guillain- …
Guillain-Barre syndrome 15 days after COVID-19 despite SARS-CoV-2 vaccination.
Finsterer J. Finsterer J. IDCases. 2021 Jul 12;25:e01226. doi: 10.1016/j.idcr.2021.e01226. eCollection 2021. IDCases. 2021. PMID: 34290962 Free PMC article.
Guillain-Barre syndrome (GBS) following a SARS-CoV-2 vaccination has been repeatedly observed but GBS following a SARS-CoV-2 infection in a vaccinated patient has not been reported. A 69yo female developed pare …
Guillain-Barre syndrome (GBS) following a SARS-CoV-2 vaccination has been repeatedly observed but …
[Guillain Barre syndrome associated with coronavac vaccine. Report of one case].
Wimmer Del-Solar J, Chávez-Martel P, Fontecilla-Villalobos E, Ibáñez-Rodríguez P, Rozas-Vidal JP. Wimmer Del-Solar J, et al. Rev Med Chil. 2022 Jan;150(1):125-130. doi: 10.4067/S0034-98872022000100125. Rev Med Chil. 2022. PMID: 35856975 Free article. Spanish.
We report a 50-year-old woman with a history of celiac disease, who presented with lumbar pain and progressive flaccid tetraparesis 48 hours after the inoculation of the first dose of CoronaVac inactivated SARS-CoV-2 vaccine. CSF was normal and electro …
We report a 50-year-old woman with a history of celiac disease, who presented with lumbar pain and progressive flaccid tetraparesis 48 hours …
What Is the Impact of the Novel Coronavirus and the Vaccination on Guillain-Barre Syndrome?
Chen Y, Li K, Lv W, Xie J, Qian Y, Cui C, Deng B. Chen Y, et al. Mol Neurobiol. 2024 Dec;61(12):9835-9850. doi: 10.1007/s12035-023-03638-8. Epub 2023 Sep 20. Mol Neurobiol. 2024. PMID: 37728848 Review.
The COVID-19 pandemic, caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), has resulted in devastating medical and economic consequences worldwide over the past 3 years. As the pandemic enters a new stage, it is essent …
The COVID-19 pandemic, caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), has …
Neurological Involvements of SARS-CoV2 Infection.
Gasmi A, Tippairote T, Mujawdiya PK, Gasmi Benahmed A, Menzel A, Dadar M, Bjørklund G. Gasmi A, et al. Mol Neurobiol. 2021 Mar;58(3):944-949. doi: 10.1007/s12035-020-02070-6. Epub 2020 Oct 16. Mol Neurobiol. 2021. PMID: 33064267 Free PMC article. Review.
COVID-19 is a pandemic viral infection caused by a novel coronavirus, SARS-CoV2, which is a global concern of the twenty-first century for its rapid spreading in a short period. Apart from its known acute respiratory involvements, the CNS manifestations of COVID …
COVID-19 is a pandemic viral infection caused by a novel coronavirus, SARS-CoV2, which is a global concern of the twenty-first …
A Pediatric Case of Sensory Predominant Guillain-Barre Syndrome Following COVID-19 Vaccination.
Kim Y, Zhu Z, Kochar P, Gavigan P, Kaur D, Kumar A. Kim Y, et al. Child Neurol Open. 2022 Jan 25;9:2329048X221074549. doi: 10.1177/2329048X221074549. eCollection 2022 Jan-Dec. Child Neurol Open. 2022. PMID: 35097156 Free PMC article.
Over six billion doses of Coronavirus Disease 2019 (COVID-19) vaccines have been administered worldwide. Amidst the global COVID-19 vaccination campaign, vaccine-related side effects are of ongoing concern and investigation. ...Whi …
Over six billion doses of Coronavirus Disease 2019 (COVID-19) vaccines have been administered worldwide. Amidst the glo …
Facial Diplegia Variant of Guillain-Barre Syndrome in Pregnancy Following COVID-19 Vaccination: A Case Report.
Zubair AS, Bae JY, Desai K. Zubair AS, et al. Cureus. 2022 Feb 17;14(2):e22341. doi: 10.7759/cureus.22341. eCollection 2022 Feb. Cureus. 2022. PMID: 35371813 Free PMC article.
Serious neurologic complications from coronavirus disease 2019 (COVID-19) vaccination are rare, and only a few cases of Guillain-Barre syndrome (GBS) have been reported after COVID-19 vaccination. ...Nasal swab testing for s …
Serious neurologic complications from coronavirus disease 2019 (COVID-19) vaccination are rare, and only a few cases of …
Emerging infectious diseases, vaccines and Guillain-Barre syndrome.
Koike H, Katsuno M. Koike H, et al. Clin Exp Neuroimmunol. 2021 Aug;12(3):165-170. doi: 10.1111/cen3.12644. Epub 2021 May 17. Clin Exp Neuroimmunol. 2021. PMID: 34230841 Free PMC article. Review.
The association between coronavirus disease 2019 (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and GBS is another emerging research hotspot. ...Recent studies have shown the efficacy of new …
The association between coronavirus disease 2019 (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus …
Post COVID-19 Vaccination-Associated Neurological Complications.
Assiri SA, Althaqafi RMM, Alswat K, Alghamdi AA, Alomairi NE, Nemenqani DM, Ibrahim ZS, Elkady A. Assiri SA, et al. Neuropsychiatr Dis Treat. 2022 Feb 2;18:137-154. doi: 10.2147/NDT.S343438. eCollection 2022. Neuropsychiatr Dis Treat. 2022. PMID: 35140464 Free PMC article.
PURPOSE: Neurological sequelae after COVID-19 vaccination are rare. We investigated the possible pathogenesis behind the development of neurological complications within a short period after Saudi residents received a COVID-19 vaccine. .. …
PURPOSE: Neurological sequelae after COVID-19 vaccination are rare. We investigated the possible pathogenesis behind th …
Post-marketing active surveillance of Guillain Barre Syndrome following COVID-19 vaccination in persons aged 12 years in Italy: A multi-database self-controlled case series study.
Morciano C, Spila Alegiani S, Menniti Ippolito F, Belleudi V, Trifirò G, Zanoni G, Puccini A, Sapigni E, Mores N, Leoni O, Monaco G, Clagnan E, Zappetti C, Bovo E, Cutillo M, Da Cas R, Massari M. Morciano C, et al. PLoS One. 2024 Jan 19;19(1):e0290879. doi: 10.1371/journal.pone.0290879. eCollection 2024. PLoS One. 2024. PMID: 38241309 Free PMC article.
BACKGROUND: Recently published studies have reported association of COVID-19 vaccine ChAdOx1-S (Vaxzevria) with Guillain Barre Syndrome (GBS). Less is known about the safety of other COVID-19 vaccines with respect to GBS out …
BACKGROUND: Recently published studies have reported association of COVID-19 vaccine ChAdOx1-S (Vaxzevria) with Guil …
Guillain-Barre syndrome with T-cell receptor gene clonal rearrangement following COVID-19 vaccination: a case report.
Matsumoto K, Morioka T, Tokuda K, Arai S, Matsuo T, Shirasaki R, Ooi J, Tashiro H. Matsumoto K, et al. Clin Exp Vaccine Res. 2025 Jul;14(3):294-297. doi: 10.7774/cevr.2025.14.e26. Epub 2025 Jun 13. Clin Exp Vaccine Res. 2025. PMID: 40741058 Free PMC article.
The occurrence of Guillain-Barre syndrome (GBS) following coronavirus disease 2019 (COVID-19) vaccination have been documented; however, its pathogenesis remains unclear. ...This case suggests that aberrant T-cell clonal expansion may contribute …
The occurrence of Guillain-Barre syndrome (GBS) following coronavirus disease 2019 (COVID-19) vaccination …
Analysis of Post-COVID-19 Guillain-Barre Syndrome over a Period of One Year in the University Hospital of Split (Croatia).
Dunkić N, Nazlić M, Dunkić V, Bilić I. Dunkić N, et al. Neurol Int. 2023 Nov 6;15(4):1359-1370. doi: 10.3390/neurolint15040086. Neurol Int. 2023. PMID: 37987459 Free PMC article.
The virus SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) is capable of attacking the nervous system in several ways and leading to neurological diseases such as GBS (Guillain-Barre syndrome) through the resulting neurotropism and i …
The virus SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) is capable of attacking the nervous system in se …
Guillain-Barre Syndrome in Mexico: An Updated Review Amid the Coronavirus Disease 2019 ERA.
Galnares-Olalde JA, López-Hernández JC, García-Grimshaw M, Valdés-Ferrer SI, Briseño-Godínez ME, de-Sarachaga AJ, Alegría-Loyola MA, Bazán-Rodriguez A, Martínez-Jiménez E, Vargas-Cañas ES. Galnares-Olalde JA, et al. Rev Invest Clin. 2022 May 1;74(3):121-130. doi: 10.24875/RIC.22000006. Rev Invest Clin. 2022. PMID: 35345064 Review.
Historically, GBS has been linked to infections (mainly gastrointestinal by Campylobacter jejuni) and vaccines (including those against severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]); however, a trigger cannot be detected in most …
Historically, GBS has been linked to infections (mainly gastrointestinal by Campylobacter jejuni) and vaccines (including those again …
Electromyoneurography and laboratory findings in a case of Guillain-Barre syndrome after second dose of Pfizer COVID-19 vaccine.
Scendoni R, Petrelli C, Scaloni G, Logullo FO. Scendoni R, et al. Hum Vaccin Immunother. 2021 Nov 2;17(11):4093-4096. doi: 10.1080/21645515.2021.1954826. Epub 2021 Aug 4. Hum Vaccin Immunother. 2021. PMID: 34347563 Free PMC article.
We present a case of GBS after receiving the second dose of Pfizer-COVID 19 vaccine. Diagnosis was made after performing an accurate clinical examination, electromyoneurography and laboratory tests. ...During this pandemic with ongoing worldwide mass vacci …
We present a case of GBS after receiving the second dose of Pfizer-COVID 19 vaccine. Diagnosis was made after performin …
A case of Guillain-Barre syndrome after the second dose of AstraZeneca COVID-19 vaccination.
Bazrafshan H, Mohamadi Jahromi LS, Parvin R, Ashraf A. Bazrafshan H, et al. Turk J Phys Med Rehabil. 2022 Jun 1;68(2):295-299. doi: 10.5606/tftrd.2022.9984. eCollection 2022 Jun. Turk J Phys Med Rehabil. 2022. PMID: 35989967 Free PMC article.
Coronavirus disease 2019 (COVID-19) is a novel virus that primarily involves the respiratory system. Due to the COVID-19 pandemic, an extensive vaccination program is underway worldwide. Herein, we present a 68-year-old woman with paresthesia of …
Coronavirus disease 2019 (COVID-19) is a novel virus that primarily involves the respiratory system. Due to the COVID- …
Post-adenoviral-based vaccines Guillain-Barre Syndrome: A proposed mechanism.
Kadkhoda K. Kadkhoda K. Med Hypotheses. 2022 Mar;160:110792. doi: 10.1016/j.mehy.2022.110792. Epub 2022 Feb 12. Med Hypotheses. 2022. PMID: 35185263 Free PMC article.
Despite great public health advances achieved by COVID-19 vaccines, rare side effects may impact the public acceptance. Guillain-Barre Syndrome has increasingly been reported with adenoviral-based vaccines. This perspective proposes a pos …
Despite great public health advances achieved by COVID-19 vaccines, rare side effects may impact the public acceptance. …
Deciphering changes in the incidence of the Guillain-Barre syndrome during the COVID-19 pandemic: a nationwide time-series correlation study.
Lee H, Heo N, Kwon D, Ha J. Lee H, et al. BMJ Neurol Open. 2022 Dec 30;4(2):e000378. doi: 10.1136/bmjno-2022-000378. eCollection 2022. BMJ Neurol Open. 2022. PMID: 36618976 Free PMC article.
Sociobehavioural interventions implemented during the COVID-19 pandemic have altered the infectious disease landscape. METHODS: This nationwide time-series correlation study analysed GBS incidence, sentinel surveillance and SARS-CoV-2 vaccina …
Sociobehavioural interventions implemented during the COVID-19 pandemic have altered the infectious disease landscape. METHODS …
Incidence and characteristics of Guillain-Barre syndrome in Taiwan before and during the COVID-19 pandemic: A 12-year single-center experience.
Chen YH, Lai KL, Lee YC, Liao YC. Chen YH, et al. J Chin Med Assoc. 2025 Jul 1;88(7):503-512. doi: 10.1097/JCMA.0000000000001251. Epub 2025 May 30. J Chin Med Assoc. 2025. PMID: 40442888 Free PMC article.
BACKGROUND: There is substantial regional disparity in the presentation of Guillain-Barre syndrome (GBS), and coronavirus disease 2019 (COVID-19) possibly influences the development of GBS, but the association remains uncertain. ...COVID-19 …
BACKGROUND: There is substantial regional disparity in the presentation of Guillain-Barre syndrome (GBS), and coronavirus dise …
Guillain-Barre syndrome related to SARS-CoV-2 vaccinations.
Finsterer J, Scorza CA, Scorza FA. Finsterer J, et al. Clinics (Sao Paulo). 2022 Jan-Dec;77:100113. doi: 10.1016/j.clinsp.2022.100113. Epub 2022 Sep 12. Clinics (Sao Paulo). 2022. PMID: 36137343 Free PMC article. No abstract available.
GM1 ganglioside antibody and COVID-19 related Guillain Barre Syndrome - A case report, systemic review and implication for vaccine development.
Dufour C, Co TK, Liu A. Dufour C, et al. Brain Behav Immun Health. 2021 Mar;12:100203. doi: 10.1016/j.bbih.2021.100203. Epub 2021 Jan 13. Brain Behav Immun Health. 2021. PMID: 33462567 Free PMC article.
BACKGROUND: Guillain Barre Syndrome (GBS) and Miller Fisher Syndrome (MFS) are emerging as known consequences of COVID-19 infection. ...Further understanding of the disease mechanism of pandemic era GBS and MFS, including antigen target(s) of COVID …
BACKGROUND: Guillain Barre Syndrome (GBS) and Miller Fisher Syndrome (MFS) are emerging as known consequences of COVID- …
Guillain-Barre syndrome following the first dose of SARS-CoV-2 vaccine: A temporal occurrence, not a causal association.
Ogbebor O, Seth H, Min Z, Bhanot N. Ogbebor O, et al. IDCases. 2021;24:e01143. doi: 10.1016/j.idcr.2021.e01143. Epub 2021 Apr 30. IDCases. 2021. PMID: 33968610 Free PMC article.
Safety monitoring is of paramount importance for vaccines authorized for emergent use (EUA) by the US Food and Drug Administration (FDA) against SARS-CoV-2. ...We report a case of Guillain-Barre syndrome after the first dose of SARS …
Safety monitoring is of paramount importance for vaccines authorized for emergent use (EUA) by the US Food and Drug Administration (F …
Guillain-Barre syndrome and fulminant encephalomyelitis following Ad26.COV2.S vaccination: double jeopardy.
Stefanou MI, Karachaliou E, Chondrogianni M, Moschovos C, Bakola E, Foska A, Melanis K, Andreadou E, Voumvourakis K, Papathanasiou M, Boutati E, Tsivgoulis G. Stefanou MI, et al. Neurol Res Pract. 2022 Feb 8;4(1):6. doi: 10.1186/s42466-022-00172-1. Neurol Res Pract. 2022. PMID: 35130960 Free PMC article.
This correspondence comments on a published article presenting a case of rhombencephalitis following SARS-CoV-2-vaccination with the mRNA vaccine BNT162b2 (Pfizer/BioNTech). We also present the case of a 47-year-old man who developed Guillain …
This correspondence comments on a published article presenting a case of rhombencephalitis following SARS-CoV-2-vacc …
Neurological manifestations associated with COVID-19 vaccine.
Alonso Castillo R, Martínez Castrillo JC. Alonso Castillo R, et al. Neurologia (Engl Ed). 2025 Jan-Feb;40(1):66-76. doi: 10.1016/j.nrleng.2022.09.007. Epub 2022 Oct 23. Neurologia (Engl Ed). 2025. PMID: 36288776 Free PMC article. Review.
In this context, many vaccines have emerged to try to deal with this disease. OBJECTIVE: To review the reported cases of neurological manifestations after the application of COVID-19 vaccines, describing clinical, analytical and neuroimaging findings a …
In this context, many vaccines have emerged to try to deal with this disease. OBJECTIVE: To review the reported cases of neurological …
COVID-19-Associated Neurological Complications in Children.
Sangeetha S, Divya N, Kumar S, Ar S, Chandrika R. Sangeetha S, et al. Iran J Child Neurol. 2024 Fall;18(4):47-60. doi: 10.22037/ijcn.v18.43364. Epub 2024 Sep 29. Iran J Child Neurol. 2024. PMID: 39478943 Free PMC article.
MATERIALS & METHODS: Case records of patients less than 18 years admitted between July 2021 to December 2022 with neurological manifestations and COVID-19 infection or with elevated COVID-19 antibodies after exclusion of other etiological diagnosis …
MATERIALS & METHODS: Case records of patients less than 18 years admitted between July 2021 to December 2022 with neurological manifesta …
A Novel Case of Bifacial Diplegia Variant of Guillain-Barre Syndrome Following Janssen COVID-19 Vaccination.
Prasad A, Hurlburt G, Podury S, Tandon M, Kingree S, Sriwastava S. Prasad A, et al. Neurol Int. 2021 Aug 13;13(3):404-409. doi: 10.3390/neurolint13030040. Neurol Int. 2021. PMID: 34449715 Free PMC article.
Guillain-Barre syndrome (GBS) is an immune-mediated demyelinating disorder which attacks the peripheral nervous system. ...We present a rare case of a bi-facial diplegia variant of GBS, within four weeks of the COVID-19 vaccination. Due to its c …
Guillain-Barre syndrome (GBS) is an immune-mediated demyelinating disorder which attacks the peripheral nervous system. ...We …
[NEUROLOGICAL MANIFESTATIONS ASSOCIATED WITH COVID-19 VACCINE].
Castillo RA, Castrillo JCM. Castillo RA, et al. Neurologia. 2022 Oct 12. doi: 10.1016/j.nrl.2022.09.005. Online ahead of print. Neurologia. 2022. PMID: 36245941 Free PMC article. Spanish.
In this context, many vaccines have emerged to try to deal with this disease. OBJECTIVE: To review the reported cases of neurological manifestations after the application of COVID-19 vaccines, describing clinical, analytical and neuroimaging findings a …
In this context, many vaccines have emerged to try to deal with this disease. OBJECTIVE: To review the reported cases of neurological …
COVID-19 and neuromuscular disorders.
Guidon AC, Amato AA. Guidon AC, et al. Neurology. 2020 Jun 2;94(22):959-969. doi: 10.1212/WNL.0000000000009566. Epub 2020 Apr 13. Neurology. 2020. PMID: 32284362 Review.
The coronavirus 2019 (COVID-19) pandemic has potential to disproportionately and severely affect patients with neuromuscular disorders. ...This article reviews (1) potential neuromuscular complications of COVID-19, (2) assessment and mitigation of C …
The coronavirus 2019 (COVID-19) pandemic has potential to disproportionately and severely affect patients with neuromuscular d …
Co-VAN study: COVID-19 vaccine associated neurological diseases- an experience from an apex neurosciences centre and review of the literature.
Samim MM, Dhar D, Arshad F, Anudeep DDS, Patel VG, Neeharika SR, Dhamija K, Ravindranath CM, Yadav R, Raja P, Netravathi M, Menon D, Holla VV, Kamble NL, Pal PK, Nalini A, Vengalil S. Samim MM, et al. J Clin Neurosci. 2023 Feb;108:37-75. doi: 10.1016/j.jocn.2022.12.015. Epub 2022 Dec 23. J Clin Neurosci. 2023. PMID: 36586226 Free PMC article. Review.
BACKGROUND: Recent studies have shown various neurological adverse events associated with COVID-19 vaccine. OBJECTIVE: We aimed to retrospectively review and report the neurological diseases temporally associated with COVID-19 vaccine. .. …
BACKGROUND: Recent studies have shown various neurological adverse events associated with COVID-19 vaccine. OBJECTIVE: …
Population-Based Incidence of Guillain-Barre Syndrome During Mass Immunization With Viral Vaccines: A Pooled Analysis.
Wang F, Wang D, Wang Y, Li C, Zheng Y, Guo Z, Liu P, Zhang Y, Wang W, Wang Y, Hou H. Wang F, et al. Front Immunol. 2022 Feb 3;13:782198. doi: 10.3389/fimmu.2022.782198. eCollection 2022. Front Immunol. 2022. PMID: 35185881 Free PMC article.
The pooled incidence rate of GBS was 3.09 per million persons (95% confidence interval [CI]: 2.67 to 3.51) within six weeks of vaccination, equally 2.47 per 100,000 person-year (95%CI: 2.14 to 2.81). Subgroup analyses illustrated that the pooled rates were 2.77 per million …
The pooled incidence rate of GBS was 3.09 per million persons (95% confidence interval [CI]: 2.67 to 3.51) within six weeks of vaccinatio …
485 results